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ABSTRACT 
Building a Genetic System in Yeast 
to Search for High Affinity Proteins in Sequence Space 
 
Matthew Douglas Merguerian 
 
  Binding proteins (both natural and man-made) have the ability to bind tightly and specifically with 
small molecules and other biopolymers.  Binding proteins can function as human therapeutics, 
diagnostics, and as tools for scientific research.  Given the wide range of potential applications, there is 
great interest in both academia and industry to develop methods for discovering novel binders.  An 
important step in discovering new binders is called affinity maturation, when an initial hit that shows some 
ability to bind the target is further mutated in additional steps to improve binding affinity, specificity, 
solubility, pharmacokinetic profile.  Ideally, the methods for affinity maturation would allow for cookbook 
protocols, be successful for arbitrary targets of interest, and be minimally resource intensive.  Although 
traditional methods for affinity maturation have had some stunning successes over the past, the state of 
the field is still far from this ideal.  In Chapter 1, I discuss the current state of the protein engineering field.  
In Chapter 2, I discuss the use of phenotypic selection for yeast-display protein binders, and test these 
systems on simple loop libraries..  In Chapter 3, I construct a genetic system in yeast that can mutate a 
protein loop via homologous recombination, and test its recombination function.  In Chapter 4, I mate 
libraries that target two different loops, and run FACS on the combinatorial libraries. In Chapter 5, I 
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Chapter 1  
Searching for functional protein binders in sequence space 
 
1.1 Abstract 
Protein binders with high affinity and high specificity for their ligand are invaluable handles on the 
nanoscale world that allow us to investigate and manipulate biological systems with surgical precision.  
Current technologies for searching for these high-functioning binders in mutational sequence space still 
sample only an insignificant fraction of all possible variants.  In this chapter, I present the idea for a 
genetic system in Saccharomyces cerevisiae capable of combinatorially walking through sequence space 
through repeated rounds of mutagenesis and selection in vivo.  This genetic system brings together a 
number of different components which are introduced and discussed here.  These include a heritable 
recombination system for cassette based mutagenesis (recently developed by our lab), the robust yeast 
display system for selection of high-affinity binders, the fibronectin-based monobody domain which serves 
as our scaffold for building binders, and the SH2 domains which serve as our target of binding.   
 
1.2 Binding proteins 
Proteins perform an overwhelmingly diverse set of functions within living organisms.  They can 
catalyze highly specific chemical reactions.  Some transport proteins are molecular motors that can ferry 
cellular cargo to and fro along the skeletal roadways of the cell.   Other transport proteins are located in 
the cell membrane and function in homeostasis, bringing vital nutrients from the outside world into the 
cell’s interior and regulating flux of ions. Some proteins are largely structural, providing shape to the cell 
and allowing cells to adhere to their environment
1
.  And many proteins function in molecular recognition 
by binding to other molecules in the cell.  The promise of protein engineering is that one day this vast 
array of functionality will be at our technological disposal. 
The binding function of proteins is well understood at a basic level.  Targets of binding, called 
ligands, can be essentially anything: informational polymers like DNA and RNA, other proteins (including 
2 
 




.  Binding proteins can 
grab onto their ligands and hold them with a certain tightness, a quality which is called affinity.  An 
experimentally determined parameter called the equilibrium constant of dissociation, or Kd, is very often 
used as the quantitative measure of affinity.  If we think of two proteins A and B that can bind to each 
other in a 1:1 ratio, we can think of their interaction symbolically as an equilibrium between two reactions, 
the dissociation reaction of the complex and the association reaction of the individuals  
    
   
→ 
    
←        
The equilibrium dissociation constant then is the ratio of the kinetic rates for the two reactions. 
    
    
   
 
In protein affinity maturation, the goal is generally to increase affinity, and thus decrease Kd.  A protein’s 
affinity for its ligand is a function of the geometric complementarity of the atoms at the binding interface, 
the chemical complementarity (e.g., acidic vs basic residues), and the flexibility of the protein at the 
interface
2,3




 M range (nanomolar or nM) are considered high 




 M (picomolar, or pM are considered very high affinity, and 10
-12
 M and 
below (femtomolar or fM) are considered extremely high affinity.  Some proteins will be promiscuous, 
binding to many different proteins
4,5
.  Others will be highly specific, binding strongly only to one or two 
other cellular components.  The ability to discern one potential ligand from another makes proteins a 
handle on the molecular world, which makes them incredibly useful. 
 
Antibodies are the most familiar class of binding proteins, and the wide variety of applications that 
have been found for them underscores the ever-increasing importance of affinity reagents
6
.  Antibodies 
have come to be indispensable tools for scientific research.  In immunoblotting, antibodies are used to 
specifically label a ligand of interest, which allows scientists to confirm the presence or absence of that 
ligand in the cells that they are studying
7
.  Moreover, antibodies that are affixed to a solid substrate can 
be used to separate and purify the ligand from a complex molecular milieu, such as a cell lysate.  In 
making a clinical diagnosis of disease, antibodies are used to stain specific molecular markers, which can 
3 
 
be visualized under a microscope by a pathologist
8
.  This ability to read molecular signatures is becoming 
more important as clinicians search for molecular markers to tell apart diseases that appear to be grossly 
similar but that have different prognoses and therapeutic susceptibilities.  For example, the estrogen, 
progesterone, and HER2 biomarkers are used to diagnose subtypes of breast cancer, which are then 
treated with tageted therapies (trastuzumab for HER2 positive, tamoxifen for estrogen receptor positive).  
Antibodies can also be used to activate or inhibit physiologic targets, such as cell-signaling receptors, and 
thus have found much application recently as therapeutic agents for cancer and autoimmune disorders
9–
14
.  These are all applications for which there already is and will increasingly be a demand for affinity 
reagents 
 Antibodies have a number of limitations as affinity reagents
15,16
.  They are large in size and 
difficult to express at high-concentrations.  The complicated structure also makes it extremely difficult to 
express antibodies recombinantly in different organisms that researchers might wish to study.  Expression 
from eukayotic cell culture is necessary to have proper folding and glycosylation.    Structurally, they are 
held together by multiple disulfide linkages, and so they must be kept under oxidizing conditions in order 
to function properly.  Thus, despite being excellent handles on the molecular world, antibodies are not 
viable for studying the intracellular environment of living cells, where they might otherwise find a great 
deal of scientific application. 
 Given these considerations, many research groups have identified alternative scaffolds that are 
useful for building affinity reagents
15,17–20
.  Alternative scaffolds are protein domains that have certain 
properties in common, such as a highly stable core that drives folding and solvent exposed regions that 
can tolerate a large amount of mutation.  This allows a certain amount of reliability in using these domains 
as starting points for mutation and selection.  Anytime you start a new binder evolution project, there is a 
well-defined region of the molecule to mutate (analogous to the hypervariable loops in antibodies
21
), and 
it can reasonably be expected that a large fraction of the resulting mutants will fold.  Thus, there is some 
degree of structural separation of the two functions of the protein: residues responsible for driving folding 
are separate from those that are most likely to form a binding interface, which allows us to think of these 





 The monobody scaffold  (Figure 1-1), or 
10
Fn3, is one of the most widely used of these alternative 
scaffolds, and it is the one we decided to use in the present study.  
10
Fn3 was first utilized for directed 
evolution by Koide
22
.  It is derived from the 94-residue 10
th
 human fibronectin type III domain
23–25
 and has 
an Ig-type fold structure
26




  characteristics  that allow it to be 
remarkably tolerant of mutation
30,31
.  Monobodies have been used with phage display, yeast display, and 
mRNA display
24
.  It has even found therapeutic application as CT-322, an anti-angiogenic agent
32–35
.  It 
has successfully been used to target diverse targets, such as estrogen receptor, ySUMO, Abl1 SH2
36
, 
MBP, epidermal growth factor receptor
37






1.3 Yeast display  
 In order to use directed evolution (see below) to search for high affinity monobodies, we require a 
method to select for the desired binding function.  A number of robust display technologies are available 
that serve the purpose of connecting phenotype with genotype by physically linking each DNA molecule 
a) b) 
Figure 1-1.  
10
Fn3 domain shown from two angles.  β strands 
named alphabetically from A-G.  The three loops commonly 
targeted for mutagenesis are the BC loop (light blue), the DE 
loop (yellow), and the FG loop (orange). 
b) rotated ~60° relative to a) 
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with its corresponding protein variant.  The most commonly used are yeast display and phage display
40–
44
.  mRNA and ribosome display
45–47
 are also worthy of note for their very large library sizes but are 
technically challenging to work with. 
The phenotypic selection that we use in our present work is based on the yeast display platform 
developed and described by Boder and Wittrup
48
.  The basic idea (Figure 1-2) is that the protein scaffold 
to be diversified is translationally fused to a membrane protein, Aga2p that is expressed on the surface of 
yeast cells.  The expression is inducible, since the fusion protein is under the control of the GAL1 
promoter.  When the cells are grown in the presence of galactose (induction), the fusion is expressed on 
the surface; when cells are grown in the presence of glucose, the expression is repressed.  Boder et al. 
determined that there are about 3x10
4
 copies of the fusion protein displayed on the surface of the 
average galactose-induced yeast cell by comparing the fluorescence intensity of yeast displaying cells to 
reference standard microspheres.   
 
 
Yeast display is a robust and mature technology
44
, which gave us a great deal of confidence 
when planning on incorporating it into our genetic system.  Many aspects of yeast display have been 
optimized, and detailed protocols have been written for effectively implementing the platform for new 
targets
49–51
.  Yeast display was used successfully to obtain a femtomolar binder
52
, demonstrating its 
ability to make In a direct comparison between yeast display and phage display in targeting HIV-1 gp120, 
Figure 1-2.  Schematic of 
yeast cell surface display, 
adapted from Chao et al. 
2006.  The scaffold of interest 
(in this case an scFv) is 
shown in blue, binding to its 




more high-affinity clones were obtained from the yeast library
53
.  It has been applied towards the affinity 
maturation of computational hits
54
.  
Yeast display allows two different, but complementary, selection modalities to be used in binder 
evolution, and both were exploited in for this monobody project.  Ligand-coated magnetic beads enable 
high-throughput selection of binders
55
.  In this selection, binding proteins on the surface of the yeast bind 
to ligand on the surface of the bead, linking the cell and the bead.  A magnetic field is then applied, which 
pulls the beads to the side of the tube, along with any cells that are bound.  Cells with non-functional 
binding variants remain in suspensions, and are then pipette off, leaving just the functional binders on the 
beads.  As a result of avidity, even binders with modest affinity are retained.  This is important in a 
combinatorial mutagenesis system such as ours, since a moderate functioning binder might actually go 
on to become a high-affinity binder after the following round of mutagenesis, and we would not like to 
remove its genes from the pool prematurely.  Flourescence activated cell sorting is the second selection 
modality, and can be used for fine affinity discriminations between binders.  Here, the ligand is covalently 
attached to a fluorophore.  A yeast cell which expresses a higher affinity binder will have more fluorescent 
ligand molecules bound to its surface, and thus will have a more intense fluorescence signal.  The 
intensity of fluorescent ligand signal can be controlled for expression level of the binder on the surface of 
the yeast cell, which crucially provides a way to distinguish between cells with high-affinity binders from 
cells with medium binders that are merely expressed at a very high copy number on the cell surface. 
One of the additional benefits of yeast is that large libraries are readily stored and propagated.  
This means that a lot of effort can be front-loaded into the construction of a large library, which can then 
be used repeatedly for many different applications (in our case, cassette libraries targeting different) 
without having to build a new library.  Feldhaus and colleagues demonstrated this with the construction of 
a 10
9
 yeast scFv library built from PCR amplification of human variable region repertoire
56
.  They showed 
that 5 rounds of propagation, each one involving passage of the cells, 100x cell amplification, and a -80 
°C freeze-thaw cycle, did not substantially alter the prevalence of a particular clone of interest, indicating 




1.4 Directed evolution of proteins 
In order to find higher affinity monobodies, this project utilizes directed evolution, a technique in 
which the Cornish Lab has substantial prior experience
57–62
.  Simply stated, directed evolution is any 
process involving repeated cycles of genetic mutation and phenotypic selection.  In terms relevant for this 
current project, a gene sequence encoding a monobody (either the “wild-type” or some low-affinity binder) 
is used as a template to create a large number of different mutant sequences.  Then, induction of yeast 
display results in the expression of monobody protein on the surface of the yeast.  In the selection, cells 
expressing proteins with higher affinity  
are physically separated from the rest.  The cycle can then be repeated by taking the winning genetic 
material from this pool, mutating it again, and selecting for function again. 
In directed evolution, the term “library” refers to the entire collection of variants that has been 
created via mutation.  In yeast display, each variant copy of the gene is contained within a yeast cell, so a 
flask or tube containing many such yeast, each with a slightly different copy of the gene, is said to contain 
the library.   There is no strong consensus in the literature with regard to terminology related to libraries.  
This leads to ambiguity, and it is worth making some quick definitions.  I call “complexity” the number of 
unique sequences contained within a library.  Following Bosley, I use “diversity” as a qualitative 
description of the average sequence difference between any two variants in the library
63
.  Lastly, I use 
“quality” in the following sense: a library that has few premature truncations due to nonsense stop codons 
and has low redundancy would be said to be of higher quality than one in which 30% of the variants were 
truncations, and 20% were all copies of a single variant
64
.   Some concerns about working with library 
complexity are addressed in Appendix I. 
The number of possible protein mutations for a fixed polypeptide length is vast (and even larger if 
length is allowed to vary).  For a rather small protein with length of 100 residues, the number of different 




.  This potential variability allows the set of all naturally 
observed proteins to have such incredibly diverse functions.  In a theoretical sense, we’d like to find the 
globally optimal sequence for the phenotypic function we wish to evolve.  The limitations of the physical 
world, however, prevent us from doing anything of this sort.  The largest library sizes achievable with 




 using mRNA display and ribosome display
46
.  This means that in 
8 
 
the very best situation (even being generous with codon degeneracy and the practical need for 
oversampling the library), we can create libraries where at most 10 residues are fully randomized.  In the 
context of binding proteins, this means that one of the three hypervariable loops of an antibody variable 
domain can be practically randomized and searched at a time.  There is clearly a need to carefully 
choose which residues will be varied, and how they will be varied, in order to limit the search of sequence 
space to a subset of sequences that you can experimentally work with
65–72
.  Library diversity is discussed 
further in Chapter 2. 
 
1.5 Affinity maturation 
Affinity maturation refers to a special type of directed evolution, where an initial hit with some 
affinity to the ligand of interest has been found, but further mutation is needed in order to obtain optimize 
obtain higher affinity or better specificity.  Here, structural studies like X-ray crystallography and 
thermodynamic studies like alanine scanning mutagenesis can be used to provide some information 
about the binding interaction.  This information can then guide further mutagenesis efforts, and thus there 
is more of a role for smart library design. 
Why is higher affinity desired?  Higher affinity binders are more potent, in the sense that a lower 
concentration of the binder is needed for the same effect.  By example, if a clinician wanted to block a 
signaling receptor in the body with a therapeutic affinity reagent, a small amount of high affinity reagent 
could block the same number of receptors as a larger amount of medium affinity reagent.  In this 
situation, poor affinity is detrimental for two reasons.  First, higher concentrations of the therapeutic can 
lead to increased side-effects, both from allergic reactions of the body against the therapeutic and from 
increased interaction of the therapeutic with secondary targets.   Secondly, protein therapeutics are 
currently very expensive to produce
16
, so higher amounts of protein per dose adds substantial cost.  The 
considerations are similar for affinity reagents in scientific research and diagnostics.  An scFv scaffold 
binder being developed as a diagnostic for prostate-specific antigen was 10-fold more sensitive for its 
target after an 8.5 fold affinity increase
73
.  A bifunctional antibody being developed as a radio-imaging 
label for tumor initially had an affinity of 10 nM for radionuclide chelates
74
.  After an affinity maturation of 
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1000-fold to 8.2 pM, the antibody demonstrated a significantly increased retention of radionuclide chelate 
in vivo. 
 Our strategy for affinity maturing binders is based on combinatorial matching of loop libraries.  
Genentech provided an excellent demonstration of the power of this mutational strategy in the 
development of an anti-VEGF antibody that would ultimately become Lucentis, a therapeutic antibody for 
macular degeneration
 ®75
.  The starting point was a monoclonal antibody with low nM affinity for VEGF.  
The Genentech team chose a targeted loop library approach, three libraries corresponding to heavy chain 
CDR loops and the fourth targeting a framework region.  A crystal structure of the original binder and 
alanine scanning data were used to limit randomization to 3-5 residues so that the maximum theoretical 
complexity could be exhaustively searched.  7 rounds of enrichment were carried out with each library, 
sequencing after the final rounds to identify the winning mutations.  Importantly, individual winner 
mutations from two of the loop libraries were then combined by site-directed mutagenesis to arrive at a 
binder with 22-fold affinity improvement over the starting point.  With our technology we hope to 
recapitulate such a mutational strategy completely in vivo, simply by mating and selecting yeast. 
 
1.6 SH2 domains 
Knowing that we wanted to use combinatorial mutagenesis to affinity mature a monobody, we 
needed a starting monobody with high affinity to an interesting target.  In 2010, our collaborators in the 
Koide Lab at the University of Chicago published the discovery of a monobody binder, called “HA4,” that 
could bind to the SH2 domain of human Abl kinase (both Abl1 and Abl2) with a Kd = 7 nM
36
.  This 
monobody was found to compete with phosphopeptide (SH2’s physiological ligand), indicating that the 
monobody was binding to an epitope on SH2 important for phosphopeptide recognition.  A crystal 
structure of HA4 in complex with Abl1 SH2 was obtained with 1.75 Å resolution.  In vivo studies 
demonstrated that transfection of mammalian cells with HA4 could inhibit processive phosphorylation of 
paxillin protein (a demonstrated substrate of Abl
76
) and inhibit phosphorylation of STAT5, a endogenous 





 Following up on this study, Wojcik and the Koide group developed a second monobody called 
7c12 which inhibited Bcr-Abl in an in vitro kinase assay, but bound to the SH2 domain on the face 
opposite from where HA4 bound
79,80
.  Capitalizing on this, they then connected the two monobodies 
covalently with a Gly-Ser linker hoping to increase affinity and specificity.  Indeed, they found increased 
potency, with the HA4-7c12 monobody inhibiting Bcr-Abl  in vitro at low micromolar concentrations.  In 
CML K562 cells, expression of HA4-7c12 resulted in decreased phosphorylation of the Tyr412 in the 
activation loop of Bcr-Abl.  The tandem monobody was found to have a pro-apoptotic effect on both CML 
cell lines and CML cells taken from patient, with a ~65% increase in apoptotic cells compared to non-
binding control in chronic phase cells.  This study validates the use of monobodies in probing cellular 
function and as tools for target validation for therapeutic development. 
 The HA4 monobody was attractive to us for a number of reasons.  The SH2 domains are 
regulators of tyrosine kinases, which act as hubs within intricate signaling networks involved in myriad 
cellular functions
81,82
.  Additionally, a crystal structure and alanine scanning results were obtained for HA4, 
which allowed us to think about loop library diversity within a structural context and provided useful 
information for troubleshooting the development of our genetic system.  Importantly, the intermediate 
library of clones from which HA4 was functionally selected was available, and we took advantage of this 
to create library diversity as discussed in Chapter 4. 
 Also of interest, the whole SH2 domain family has been recognized as an important set of targets 
to challenge our ability to develop binders with specificity
83–86
.  Many of the family members have close 
sequence and structural similarity.  A recent paper reported the development of a panel of antibodies 
specific to 20 human SH2 domains using phage display
87
.  The project was carried out in a high 
throughput manner, with an eye towards developing research tools for proteomics.  Out of an initial library 
of 10
10
 different binders, 1292 phage hits were shown to bind antigen, with at least 150 unique binders 
demonstrating “monospecificity” for one of the SH2 domains, where monospecificity was defined as  
having an ELISA binding signal for the specific target > 10 the binding signal for any of the other 19 SH2 
domains included in the panel.  The 20 SH2 domains used in this panel (a subset of the 120 SH2 
domains extant in the human genome) ranged in pairwise sequence similarity from 20-89% identity.   
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Specificity is a separate problem from affinity
2,4
, but it is an extremely important one.  The process 
of intentionally altering specificity through directed evolution is still being actively explored.  Protein 
microarray data
36
 showed that HA4 can bind to other SH2 domains, most noticeably at concentrations of 
HA4 at 32 nM.  Although not the focus of the current work, it would be interesting to try and use 
combinatorial loop “walking”
88
 to try to shift HA4’s specificity for Abl SH2 to another domain (Chapter 5).  
 
1.7 Harnessing the power of combinatorial mixing 
 In eukaryotes, sexual pairing of genes followed by homologous recombination during 
chromosomal crossover can result in genetic shuffling of a gene.  This allows mutations that arose 
independently at different locations within two copies of the same gene to be combined into a single copy 
of that gene.  This is a very successful strategy in natural evolution, as it obviates the need for two or 
more presumably rare mutations to arise sequentially within one ancestral lineage. 
 Inspired by this strategy, the Cornish lab has been interested in combining mating, homologous 
recombination, and phenotypic selection all into one system, which we call a “heritable recombination 
system” (HRS).  Romanini and coworkers from our lab have recently reported the first application of HRS 
for combinatorially crossing the beneficial mutations from separate libraries
89
.  This system had three 
major components each on a separate plasmid within a single yeast strain.  First, it had a plasmid 
containing the gene to be mutated, the TRP1 biosynthetic gene.  The second plasmid in the system is a 
cassette plasmid, which contains a mutational codon flanked by homology on both sides, which are 









The basic logic of the design (Figure 1-3a) is that the endonuclease is under the control of the 
GAL1 promoter, which has a tight repression of expression when the yeast cells are in glucose, and 
strong activation of expression in galactose.  By inducing the cells in galactose, I-SceI is expressed and 
cuts at one of the sites flanking the cassette in the cassette plasmid.  The formation of a DSB recruits the 
homologous recombination machinery of yeast
90
, which helps to find the homology on the target 
plasmid
91
, leading to transfer of the cassette mutation into the target gene. 
 Romanini first demonstrated that the system could fix a non-sense stop codon in TRP1 with the 
wild-type Arg codon with a maximal 6% efficiency.  This repair required the presence of both the I-SceI 
plasmid and the cassette flanked by I-SceI sites.  He then showed that the cassette plasmid could be 
recovered from daughter cells intact, following successful recombination, indicating that enough intact 
copies survived DSB formation and could be transmitted to other yeast cells in later rounds.  To 
showcase the mating element, Romanini moved to a more complicated experimental design and showed 
that stop codons in two separate genes on the same target plasmid could be fixed with two sequential 
Figure 1-3.  Homologous recombination of mutagenic cassette into target gene stimulated by 
endonuclease (reproduced from Fig. 2, Romanini 2012
89
).  a, A general schematic for induction of 
mutagenesis.  The endonuclease, shown as a blue pac-man, is expressed after growth in galactose and 
introduces DSB’s into the cassette plasmid “C”.  The cut ends of the cassette stimulate recombination 
with the homologous portion of the TRP1 gene (yellow) in the target plasmid “T”.  b, A close-up of the 
mutagenic cassette contained within the cassette plasmid. 
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rounds of mating and induction of homologous recombination.  This work proved the concept that 
mutational information on cassettes could be transferred horizontally, used to make mutations in a target 
gene, and then passed on again. 
 
1.8 A model system for investigating affinity maturation 
 This heritable recombination system is well suited for the affinity maturation of binders.  The 
structure of binding proteins is such that the flexible loops (complementarity determing regions or 
analogs) targeted for mutagenesis often form the key interactions with the ligand.  Since the residues 
within the loops are located in consecutive regions of the primary sequence, a single cassette can 
randomize multiple key residues in a single mutational step.  Additionally, an envisioned heritable 
recombination system for mixing and matching different binding loop sequences has a natural parallel in 
the combinatorial V(D)J system that is responsible for the expansive repertoire of the human adaptive 
immune system
92,93
.  In T and B lymphocytes, the genes for the corresponding antigen receptors 
(immunoglobulin in B cells, T-cell receptors in T cells) are made functional when a VDJ recombinase 
enzyme recognizes recombinase activating segments that flank each of the V, D, and J cassettes in the 
germline DNA and catalyzes the joining of one of each of the three cassettes.  In the Ig heavy chain, for 
example, 1 out of 100 V segments, 1 out of 27 D segments, and 1 out of 6 J segments come together, 
with 1.62 x 10
4
 possible combinations; further combination with the light chain give a combinatorial 
diversity of 10
6
 for a naïve Ig.  Given the wide variety of antigens that can be bound by antibody with this 




 In the following chapters, we discuss the construction of a heritable recombination system for 
affinity maturation of monobodies against the SH2 domain (Figure 1-4).  This system combines a 
mutagenesis system, a selection system, and mating in yeast, allowing for fully in vivo  cycles of affinity 
maturation.  This system is a significant next step in that it demonstrates the applicability of HRS in more 
technically demanding situations.  Instead of mutating a single codon to repair stop codons, this project 
requires the mutation of entire loops (8 or 9 codons) at a time.  Furthermore, due to the nature of the 
Figure 1-4.  Heritable recombination system for affinity maturation of protein 
binders.  Yeast mating brings together a monobody gene on a yeast display 
plasmid (“T” for target) and a cassette plasmid containing a mutagenic DNA 
sequence for one of the monobody loops.  The cassette diversity replaces the 
corresponding loop in the monobody gene through homologous recombination, 
and then yeast display is induced, causing the new, mutated version of the 
monobody to be expressed on the cell surface.  Selection (either magnetic 
beads or FACS is used to pick out the yeast cells with the highest affinity 
protein variants on their surface.  Additional rounds of mating allow for 
repeated cycles of mutagenesis and selection. 
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selection, it is necessary to maintain the target plasmid (containing the gene to be mutated) on a low copy 
CEN plasmid, instead of a high copy 2µ plasmid, and this comes with technical challenges as will be 
discussed in Chapter 3.  
This work is also important from a synthetic biology perspective.  The yeast display system and 
the heritable recombination system are two independent genetic systems for carrying out a biologically 
artificial function.  Synthetic biology’s future success depends on the ability to put together multiple 
exogenous, artificial genetic elements together and have them retain their function while having the cell 
retain its viability.  The platonic ideal goal is to have sets of standard signaling elements (promoters, 
repressors, enzymes, kinases) that are robust enough to operate under a wide range of conditions with 
predictable behavior and that can interface with each other, somewhat like the resistors, capacitors, and 
inductors that make up electrical circuits.  To date, efforts have been modest and have underscored the 
real-life difficulties inherent in getting messy, stochastic systems like cells to accept components that they 
have not evolved with.  By bringing together two genetic systems (yeast display and heritable 
recombination), we are pushing the envelope in this regard.  In overcoming technical hurdles for this 
project, we have obtained valuable insight into the design of sophisticated genetic systems in eukaryotes. 
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Chapter 2  
Cconstruction of BC loop libraries and Phenotypic Selection 
 
2.1 Abstract 
One half of the directed evolution equation is selection of functional binders.  In order to develop a system 
for mutagenesis, we first needed to validate the components of the functional selection.  We started by 
purifying our target GST-SH2 and functionalizing it with biotin.  We then demonstrated that magnetic 
beads coated with our target could enrich our high-affinity monobody from a mock library.  The high-
affinity phenotype was also successfully screened for by fluorescent labeling and flow cytometry.  To test 
these selections in an actual round of affinity maturation, we mutated the BC loop of a medium-affinity 
binder using gap-repair and showed using FACS that rare hits initially present at <0.055% in a 6.5 x 10
6
 
library could be enriched.  In short, we demonstrated that all of the components of the selection system 
were working, in addition to validating our choices of library diversity.  The data gave us sufficient 
confidence that this selection system could be relied upon for troubleshooting and development of a novel 
method for in vivo mutagenesis. 
 
2.2 Introduction 
The heritable recombination system for affinity maturation, as discussed in Chapter 1, is a 
sophisticated genetic system, containing a separate mutagenesis system and a selection system.  At the 
beginning of this project, we first wanted to test the components of the selection system before trying to 
interface it with the mutagenesis system.  Specifically, we needed to test the strain and plasmid required 
for yeast display on the cell surface, express and purify the Abl1 SH2 target, demonstrate the ability of 
both the magnetic beads and FACS functional screens to enrich binders from libraries, and show that we 
could build and test BC loop library mutants with all of these put together.  To provide a short-term goal to 
motivate these efforts, we decided to try to affinity mature a medium-affinity monobody.  If we could 
successfully accomplish all of these steps, then we could have confidence that the selection was working 
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robustly.  Since the Cornish Lab had no previous experience with yeast display, magnetic beads, or 
FACS, all of the materials needed to be procured and the protocols adapted and optimized. 
The yeast display system, developed by Boder and Wittrup
1
, physically links genotype and 
phenotype in yeast cells, allowing for phenotypic selection of libraries of genes.  There are two 
components of this system: the EBY100 strain of yeast and the pYD-1 plasmid.  A monobody gene can 
be inserted into pYD-1 as an in-frame fusion with the AGA2 gene.  When pYD-1 is transformed into 
EBY100, growth of the resulting strain in galactose media induces expression of the monobody protein, 
fused to aga2p on the surface of the yeast. 
Another key component needed for the project was the gene for the monobody protein scaffold.  
Our collaborators in the Koide Lab at the University of Chicago sent us the gene for the high-affinity HA4 
binder of Abl1 SH2
2
, in addition to a lower affinity variant (Kd ≈ 350 nM) of HA4 called “HA4R38A”.  These 
monobodies served as controls in the work described below.  They also provided us with the plasmid for 
expressing GST-SH2, which we need to purify and biotinylate in order to for the phenotypic selections to 
work. 
 The magnetic bead selection is a critical technique for processing new libraries, and has been 
well characterized by Ackerman and colleagues
3
.  It is high throughput, with the ability to run 10
9
 yeast 
cells in a single 1.5 mL microfuge tube.  This means that after a recent round of mutagenesis, when the 
library complexity is highest but many non-functional mutants are present, magnetic bead selection can 
quickly and easily cull the non-binders from the population before running the more expensive and 
(relatively) low-throughput FACS.  An additional feature of the magnetic bead technique is that it utilizes 
avidity, as a single bead is coated with many copies of antigen and a single yeast cell is coated with many 
copies of binder.  This means that the selection can even enrich binders with moderate function.  This is 
important for an affinity maturation scheme where multiple steps of mutation are envisioned (such as 
ours), and where weaker binders might actually be critical intermediates on the mutational pathway to 
very strong binders, and so we would prefer not to weed them out immediately.   That said, stringency 
can be tuned upwards if desired by increasing the number of wash steps, the temperature of the wash 
buffer, or the speed of mixing.  Ackerman also demonstrated that beads could retain rare clones.  She did 
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this by mixing a micromolar (low affinity) binder with non-binding cells in ratios as rare as 1 in 10
5
, and 
then showing that the binding clone was enriched to a post-selection prevalence of 1 in 3. 
Finally, FACS would ultimately be needed in order to identify the very high affinity binders.  FACS 
is well-suited for fine affinity discrimination.  Importantly, it allows researchers to control for the copy-
number variation of binders on the surface when analyzing the antigen binding signal. It has the added 




Using magnetic beads and FACS in combination is key.  There are stochastic elements in the 
FACS process that could cause rare cells to be lost, even if they have very high-affinity binders.  For 
instance, sometimes two cells sticking to each other will go through the detection laser at the same time.  
Forward scattering and back scattering measurements by the instrument will be used to automatically 
discard these cells since they don’t appear to have the shape and size of the rest of the yeast that are 
being examined.  It is critical, then, to perform a low-stringency selection to increase the multiplicity of the 




 To start testing the functionality of the selections, we first needed to purify the SH2 domain that 
the monobodies targeted.  From the Koide Lab, we obtained plasmid pGST-SH2 for expressing a fusion 
protein of the human Abl1 SH2 domain and glutathione-S-transferase (GST)
2
.  Fusion to GST increases 
the solubility of the protein and provides a purification alternative to the N-terminal 6-histidine tag.  The 
GST domain is located on a face of SH2 opposite from the HA4 binding epitope, so it does not interfere 
with the HA4 interaction.  The GST domain also contains an N-terminal cysteine residue for biotin-tagging 
chemistry.  We expressed the GST-SH2 fusion protein in BL21 DE3 E. coli cells using the auto-induction 
protocol of Studier
6
 (Figure 2-1a).  The GST-SH2 fusion was purified by its 6-histidine tag on a Ni
2+
 
Sepharose ion affinity column (Figure 2-1b).  On average, each 500 mL of auto-induction culture yielded 
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4-5 mg of GST-SH2 after a single column purification.  More GST-SH2 was expressed than this however, 
and multiple column purifications of “dirty” fractions could be used to enhance yield. 
 
 
   The free cysteine in the GST domain was utilized to covalently attach biotin to the GST-SH2.  In 
both the magnetic bead selection and FACS screening, the biotin is used as a handle for the SH2 





in FACS, fluorescent phycoerythrin is conjugated to streptavidin.  In this way, SH2 can be attached to a 
solid-phase or fluorescently labeled, along with any yeast that happen to be binding it. 
 Originally, we used a biotinylation reagent with maleimide moiety for the covalent linkage.  After 
reaction, we used a HABA (4'-hydroxyazobenzene-2-carboxylic acid) colorimetric assay to estimate the 
molar ratio of biotin:GST-SH2.  After multiple trials of reactions at different conditions, we obtained molar 
ratios ranging from 1.7 – 4.3.  There is only one cysteine in the translated GST-SH2 protein, so we 
expected a molar ratio of about 1:1.  Higher ratios imply that the average GST-SH2 molecule is 
biotinylated at more than one residue.  Since the maleimide moiety in the biotinylation reagent is 
potentially reactive towards lysine residues as well, over-biotinylation might signify the presence of 
unwanted biotins at the HA4 binding epitope that could ruin the selection.    As a result, I switched to a 
disulfide biotinylation reagent, which is more specific for the cysteine.  Though this conjugation is 
reversible by reduction, we anticipated that this would not be a problem for our applications. 
 
GST-SH2 37 kDa 
50 kDa 
(b) (a) 
Figure 2-1.  Expression and purification of GST-SH2 fusion protein.  a, 
GST-SH2 is visibly over-expressed after auto-induction overnight.  b, 
FPLC elution gradient is capable of producing pure GST-SH2. 
pure 
GST-SH2 
elution gradient flow wash 
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Magnetic Bead Selections 
 With biotinylated GST-SH2 in hand, we wanted to test both the yeast display of HA4 and the 
magnetic bead selection.  We cloned the high-affinity HA4 monobody into the yeast display plasmid which 
was then transformed into EBY100 yeast to make ysEBYHA4.  For a negative control, we made a strain 
displaying a non-sense truncation monobody (ysEBYR38A*), and for a positive control we made a strain 
(ysEBYL751) displaying an extremely high-affinity monobody developed by the Wittrup Lab that targets 
lysozyme
8
.   The first experiment examined whether cells could display monobody and stick to the 
magnetic beads (Table 2-1).  We induced yeast display in each of the three cell strains and incubated 
them separately with magnetic beads.  After the initial incubation of the cells with the beads and magnetic 
pull-down, we removed the supernatant (cells not stuck to beads) and dilution plated it in order to quantify 
cell count.  After washing the beads four times to remove non-specific binders, we dilution plated the 
captured cell population.   
 
Table 2-1.  Magnetic bead binding capacities. 
Strain Kd Cells in Supernatant Cells Captured  Beads/Cell 
ysEBYHA4  7 nM 2 x 10
7
  2.7 x 10
6
  1.9 




  5 








 target-coated magnetic beads were mixed with 5x10
8
 cells of each of the three strains displaying a different 
antibody.  “Cells in supernatant” is the number of cells not bound to the beads after 2.5 hrs incubation.  “Cells 
captured” is the number of cells attached to beads after 4x washes.  Significant figures based on number of colonies 
on dilution plates. 
 
 
We found that for both the positive control and the HA4-expressing yeast cells, the beads capture 
a total number of cells with the same order of magnitude (10
6
).  Further experiments have supported the 
finding that 2:1 beads:cell is the saturation point of the beads.  It may seem at first glance surprising that 
lower-affinity HA4 stuck in larger total numbers than L7.5.1, but consideration of binding avidity between 
cells and beads
3
 means that any reasonably high-affinity binders should be expected to perform equally 
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well.  The difference in performance seen here is within experimental error.   Some negative control cells 
still stuck to the beads after 4 washes.  Presumably under conditions where there is no competition, the 
stickiness of yeast allows this background level of selection.  In the bead selections using actual libraries 
discussed later in this and following chapters, libraries were first incubated with uncoated beads as a 
negative selection for sticky mutants; unbound cells were then transferred to a tube with SH2-coated 
beads, whereas the cells that had bound uncoated beads were discarded.  The much higher performance 
of ysEBYHA4 vs ysEBYR38A* suggests that the yeast display, the biotinylated SH2, and the magnetic 
beads were all working as anticipated. 
Before running real libraries, we needed to check that we could successfully enrich rare binders 
from a background of non-binding cells with my experimental setup.  Thus, the next step was to test the 
ability of the beads to enrich high-affinity binders from a “mock library” of EBY100 cells containing no 
display plasmid.  5 x 10
8
 yeast cells, consisting of a mixture of ~1000 background cells for every 
monobody-displaying cell, were selected with 2.5 x 10
6
 antigen-coated beads.   The pre- and post-
selection frequencies of the monobody-displaying cells was determined by dilution plating on selective 
media. 
 
Table 2-2.  Magnetic bead enrichments of mock libraries in cell frequencies. 
Monobody Pre Fraction (%) Post Fraction (%) Enrichment Ratio Theoretical Max Ratio 
HA4 0.13 93.1 695 746 
L7.5.1 0.14 61.6 440 710 




 yeast display cells with expressing a specific monobody were mixed with 5x10
8
 EBY100 cells.  Selections were 
carried out with 2.5x10
6
 beads.  Fractions (# plasmid-containing cells / # all cells) were determined both pre- and 
post-selection by dilution plating on SC(U-) and SC(UT-).  Enrichment ratio is post fraction / pre fraction.  Theoretical 
max ratio is the enrichment ratio that would be required to enrich the monobody-displaying cells from the observed 














The same experiment from Table 2-2, with data in terms of absolute cell numbers.  “Total” is the total number of yeast 
(background + monobody-displaying). 
 
 The results show that both ysEBYHA4 and ysEBYL751 enriched to a majority of the post-
selection population (Table 2-2), successfully competing with the non-binding yeast.  Both ysEBYHA4 
and ysEBYL751 appear to have reached the level of bead saturation, with about 2:1 beads:monobody 
cells captured.  ysEBYL751 performed better than ysEBYHA4 in number of monobody cells pulled down, 
but it also apparently pulled a lot of non-binding cells too, resulting in a lower post-enrichment frequency 
than ysEBYHA4 .The negative control, expressing non-functional truncated protein was not enriched at 
all.  No ysEBYR38A* colonies were found on post-selection plates, so post-enrichment fraction in Table 
2-2 and monobody post in Table 3-3 are upper-bounds.  These results importantly showed that the 
magnetic bead selection worked well even with an input of 10
9
 cells in a single microfuge tube, and is 
thus very useful as a high-throughput initial selection on a large library. 
 
Flow cytometry of HA4 
The other selection technology that this project relies upon is flow cytometry.  We validated the use of 
flow cytometry by testing it on strain ysEBYHA4 (Figure 2-2).  We induced yeast display in a culture of 
ysEBYHA4 and then incubated 10
6
 cells with biotinylated GST-SH2.  Our yeast display construct contains 
a V5 epitope tag C-terminal to the monobody, and we used an anti-V5 antibody conjugated to fluorescein 
isothiocyanate (FITC) to fluorescently label this tag.  Doing this allows us to use the FITC signal as a 
measure of how many copies of the monobody fusion are being displayed on the surface of the yeast.  
Fluorescent phycoerythrin(PE)-streptavidin was used to label the SH2 domain, and thus the PE signal 
measures the amount of ligand binding to the cells. 
Monobody Total Pre Monobody Pre Total Post Monobody Post 



























The results showed that anti-V5 antibody binds to galactose-induced ysEBYHA4, confirming the 
expression of the Aga2p-monobody fusion on the surface of the yeast.  Additionally, the positive PE 
signal suggests that biotinylated GST-SH2  can bind to both the HA4 monobody and to streptavidin.  As 
we would expect, binding to SH2 is proportional to the amount of monobody expressed on the surface of 
the yeast.  Furthermore, a lack of PE single-positive events suggests that there is no non-specific binding 
of our GST-SH2 to the yeast cell.  It is typical of yeast display that only 40-80% of cells capable of yeast 
display will actually express binder on the surface after galactose induction
9
, so the 59% of ysEBYHA4 
giving double-positive signal is an expected result.  With the two selections and the yeast display system 
working, we were at this point ready to start building and sorting libraries. 
 
Construction of BC loop libraries 
We then began construction of a few monobody libraries using established cassette mutagenesis 
methods
8,10
 so that we could test the selection methods in a real application.   The clone that we chose to 
affinity mature was HA4R38A with Kd ≈ 350 nM.   
Figure 2-2.  HA4 monobodies expressed on the surface of yeast give double-positive signal in 
flow cytometry.  FITC signal for anti-V5 antibody is plotted in log units on the X-axis.  PE signal 
for GST-SH2 is plotted in log units on the Y-axis  a, EBY100 negative control cells; all cells are 
double-negative. b, 59% of ysEBYHA4 cells show a double-positive signal.  Heat map colors 




The BC loop of the monobody structure looked appropriate target for cassette mutagenesis.  
Cassette mutagenesis is ideal for randomizing a consecutive set of residues, and so the β-hairpin loops 
are natural functional units to target.  The crystal structure for the HA4 clone and alanine scanning data 
obtained by Wojcik indicate that the FG loop makes more energetic contribution to binding
2
.   Because of 
this, we reasoned that complete replacement of the FG loop would really not be affinity maturation at all, 
but more like de novo binder discovery due to the removal of key binding contacts. The crystal structure 
also shows that only Tyr35 from the BC loop makes direct contact with the SH2 domain.   However 
Ser32-Tyr35 of the BC loop directly contact the FG loop.  It is possible then that mutation of the BC loop 
could modulate the interaction of the FG loop with the SH2 domain.  For example, a mutant BC loop 





We built our first library by replacing the BC DNA sequence with 8 randomized codons.  
Oligonucleotides were synthesized using NNB degenerate nucleotides, where N indicates an 
equiprobable mix of the four nucleotides and B indicates C, G, or T.  Such a degenerate codon has the 
ability to code for all 20 amino acids, with only a 2% chance of a stop codon.  The yeast display plasmid 
was restriction digested and cotransformed into yeast with the synthetic oligo library (Figure 2-4). 
Figure 2-3.  BC loop residues targeted for 
mutagenesis. 
The HA4 protein (magenta) is shown in complex with 
the Abl1 SH2 domain (cyan).  The BC loop, with 
residue sequence DAPMSSSSVY, is represented 
explicitly by sticks.  The Tyr35 residue makes close 
contacts with the SH2 domain.   








 successful transformants were obtained, and this serves as an approximation to the true 
library complexity.  It should be noted that this actual library complexity vastly undersamples the potential 
library complexity of 8 NNB codons.  With 48 codon possibilities at the nucleotide level, we calculate 48
8
 
= 2.8 x 10
13
 unique nucleotide sequences.  For every sequence that we have in the library, there are a 
million that are missing from the potential library.  Furthermore, each of the eight NNB codons has a 
2.08% of coding for a stop.  This means that 15.5% (calculated as 1 – 0.9792
8
) of the potential library 
members are expected to be useless since they will contain at least 1 or more stop codons in the BC 
loop. 
We then sequenced a random sample of the transformed clones to assess the quality of the 





Figure 2-4.  Gap-repair mutagenesis for construction of BC loop libraries.  Yeast display plasmid (black 
ring) was restriction digested in the center of the monobody gene (green).  Mutagenic cassettes were 
constructed by PCR with randomized codons, giving each cassette a unique sequence (rainbow 
patterns) flanked on both sides by homology to the monobody gene (green).  The cut plasmid and the 
cassettes were co-transformed into EBY100 yeast, with gap-repair by homologous recombination 



















Table 2-4.  BC residues sequence from colony PCR of 8x NNB library.  
BC residues sequences are shown for the wild-type fibronectin scaffold,  









Clone BC Loop Position 
FN3 D A P A V T V R 
HA4 D A P M S S S S 
1 G P E N R V N A 
2 G G P T D V D T 
3 T V L L P I L V 
4 T R * A * P F Q 
5 W G R P R N P R 
6 S P L R P L T S 
7 R V S D R V N P 
8 A S A A D L T G 
9 P A P V R L R R 
10 P N L P G P L P 
11 G T R P I H H E 
12 W G R H R N P R 
13 D G P F S R P A 
14 P T P A G Y A F 
15 H W L K P H R N 
16 L T L V Y R M I 
17 D V L G P N A S 
18 D D T L H R R P 
19 G Q A S H C G E 
20 P S A P P P A P 
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On visual inspection, the large number of proline and arginine residues stood out.  17/20 had at least one 
proline, and 7/20 had 2 or more.  The codon frequencies for these 20 sequences were calculated and 
compared to the theoretical frequencies for an NNB library (Table 2-5).   
 
Table 2-5.  Observed and expected residue frequencies in NNB library 
Residue # Observed Observed  (%) Expected Freq (%) Δ% 
Ser 8 5 10.42 -5.42 
Cys 1 0.625 4.17 -3.55 
Tyr 2 1.25 4.17 -2.92 
Phe 3 1.875 4.17 -2.3 
Ile 3 1.875 4.17 -2.3 
Lys 1 0.625 2.08 -1.46 
Met 1 0.625 2.08 -1.46 
Gln 2 1.25 2.08 -0.83 
Stop 2 1.25 2.08 -0.83 
Val 9 5.625 6.25 -0.63 
Glu 3 1.875 2.08 -0.21 
Trp 3 1.875 2.08 -0.21 
Thr 10 6.25 6.25 0 
His 7 4.375 4.17 0.21 
Leu 14 8.75 8.33 0.42 
Asp 8 5 4.17 0.83 
Asn 8 5 4.17 0.83 
Gly 13 8.125 6.25 1.88 
Ala 13 8.125 6.25 1.88 
Arg 20 12.5 8.33 4.17 
Pro 29 18.125 6.25 11.88 
Total 160 100% 100% 0 
 
The 8 codons from the 20 sequences were tabulated, and frequencies were calculated. 
∆% = observed % - expected % 
 
This breakdown shows greater than expected frequencies of Pro and Arg residues, and lower than 
expected frequencies of Ser, Cys, and Tyr.  Although proline residues can often be found in β-hairpin 
turns, an abundance of prolines are expected to be conformationally restrictive.  A lower frequency of Ser 
and Tyr is undesirable, as these residues tend to be enriched at binding interfaces
11–13
.  Cys residues 
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have been found to make substantial monobody libraries
14
, but it is not clear how general this result is 
and whether Cys is to be desired in our libraries.  Overall, the observed distribution seems unfavorable for 
a binding library. 
A χ
2
 test rejected the hypothesis that the expected NNB residue frequency describes our library 
with p < 0.005 (χ
2
 = 68.8 with 17 degrees of freedom).  Although this library incoporated all 20 amino 
acids as intended, the frequencies for some important amino acids were heavily skewed.  This bias could 
have been introduced at multiple points in the process of building the library: during oligo synthesis, 
cassette PCR or gap-repair. 
 For a second library, we restricted the amino acid diversity to a subset of the natural 20 in order 
to decrease the total theoretical complexity.   Our aim was to make a “smarter” designed library, where 
each individual library member would have a higher a priori probability of coding for a high-affinity 
binder
15,16
.  This strategy has been proven effective even in the extreme case where binding loop libraries 
are restricted to just serines and tyrosines, so-called binary interfaces
11,12,17
.  There are many options 
available for creating restricted diversity libraries, and construction using degenerate codons is greatly 
aided by computational tools that have been published and provided as an internet resource
18,19
.  One 
way to improve the quality of the library is to completely remove stop codons; for our 8 codon BC loop, 
16% of usable library size could be reclaimed by switching from NNB to a stop-free codon.  It is also 
desirable, for the reasons stated above, to have libraries enriched in Tyr and Ser residues. 
   We found the NNY codon to be particularly attractive.  The residue frequencies for an NNY 
library were favorable compared to the commonly used NNB and NNK codons.  Importantly, there were 
no stop codons, so truncations would not be taking a 16% bite out of our usable library like in the NNB 
case.  Furthermore, Tyr has a 50% increased frequency and Ser has a 20% increased frequency in NNY 
over NNB.  Glu, Lys, Trp, Gln, and Met are absent, but they have counterparts with similar 
physicochemical properties (suggested by the residue groupings in Table 2-6) that are still represented.  
Thus I made an 8 residue NNY library in the same manner as the NNB library.  Transformation into yeast 
gave 1.9 x 10
6





Table 2-6.  Degenerate codons and their corresponding residue frequencies 
 
NNN NNK NNB NNY 
  
 
  Aspartic Acid 3.125 3.13 4.17 6.25 
Glutamic Acid 3.125 3.13 2.08 0 
  
 
  Arginine 9.375 9.38 8.33 6.25 
Histidine 3.125 3.13 4.17 6.25 
Lysine 3.125 3.13 2.08 0 
  
 
  Phenylalanine 3.125 3.13 4.17 6.25 
Tyrosine 3.125 3.13 4.17 6.25 
Tryptophan 1.5625 3.13 2.08 0 
  
 
  Serine 9.375 9.38 10.42 12.5 
Threonine 6.25 6.25 6.25 6.25 
Cysteine 3.125 3.13 4.17 6.25 
Asparagine 3.125 3.13 4.17 6.25 
Glutamine 3.125 3.13 2.08 0 
  
 
  Glycine 6.25 6.25 6.25 6.25 
Alanine 6.25 6.25 6.25 6.25 
Proline 6.25 6.25 6.25 6.25 
Valine 6.25 6.25 6.25 6.25 
Leucine 9.375 9.38 8.33 6.25 
Isoleucine 4.6875 3.13 4.17 6.25 
Methionine 1.5625 3.13 2.08 0 
  
 
  Amber 1.5625 3.13 2.08 0 
Ochre 1.5625 0.00 0.00 0 
Opal 1.5625 0.00 0.00 0 
 
 The length of the mutated loops has also been an important source of diversity for the generation 
of high-affinity binders
8,20
.  For this reason, we also constructed NNB and NNY libraries in which 4 loop 
lengths (6, 7, 8, or 9 codons) were present in an equimolar mixture.  Hackel et al. used these 4 BC loop 
lengths to find a 3 pM binder against lysozyme
8
.  He investigated 16 different fibronectin type III domains 
across 5 different species and found that these were the most common BC loop lengths.  In the 
construction of our mixed-length libraries, I used an equimolar mixture of the 4 lengths not knowing a 
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priori which length would be the best design.  The NNB mixed-length library had 3.8x10
6
 transformants, 
and the NNY mixed-length library had 6.5x10
6
 transformants. 
 To confirm proper construction of these two libraries, I extracted whole population DNA via PCR 
and then sequenced the monobody gene.  Example data for the 8-codon NNB library is shown in Figure 
2-5a for comparison.  The 24 bp stretch of NNB and NNY nucleotides was confirmed for both libraries.  
Although peak heights cannot be used to quantitatively compare molar proportions of the different 
nucleotides, a qualitative excess of cytosine bases, as suggested in the data for both libraries, would be 
consistent with the observed overabundance of proline residues (CCN codons) noted above in the 
sequencing data for individual clones of the NNB library. 
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Figure 2-5.  Population sequencing of BC loop coding regions.  a, 8-codon NNB library, where 
green signal for A is flat every third position.  b, mixed-length NNB library.  c, mixed-length NNY 
library, note presence of G (black) signal every third base, contrary to design.  In the mixed-length 
sequence reads, the difference in length of random codons results in loss of sequence matching 
downstream of the BC region.  Adenine signal in green, thymine in red, cytosine in blue, guanine 






FACS Enrichment on Mixed-Length Libraries 
 We next used FACS screening on the two mixed-length libraries.  The mixed-length NNB library 
enriched only minimally after two rounds of FACS (Figure 2-6).  A small cluster of FITC negative, PE 
positive cells was observed (Figure 2-6b).   
 
 
 The mixed-length NNY library successfully enriched after three rounds (Figure 2-7).  There is a 
distinct population of double-positive cells.   
 
Figure 2-7.  FACS enrichment of mixed-length NNY BC loop library. a, first round of sorting.  (0.055%).  
b, third round of sorting.  A population of double-positive hits is visible.  0.14% of cells collected. 
(a) (b) 
Figure 2-6.  FACS enrichment of mixed-length NNB BC loop library.  a, first round of sorting.  0.13% of 
cells were collected.  b, second round of sorting.  A small promontory of cells with PE-positive signal is 





 In this work, we found that yeast display is a very robust technology for working with libraries of 
protein binders.  Magnetic beads were capable of capturing as many high-affinity cells as they could 
physically hold, even at extremely high cell densities (10
9
 cells per tube).  FACS was able to distinguish 
high-affinity binders from background and to enrich binding populations from rarity hits in actual BC loop 
libraries.  Finally, the successful enrichment validated NNY codons as a source of diversity for affinity 
maturation.  The fact that we obtained enrichment after loop replacement is validation of the NNY library 
as source of diversity for affinity maturation.   
 Our main goal at this early stage was to successfully build libraries with conventional gap-repair 
mutagenesis and then demonstrate enrichment.  The affinity of the enriched binder populations from the 
mixed-length libraries could undoubtedly be improved further by many additional rounds of mutagenesis, 
involving at each step 1) extraction of the plasmid DNA from these yeast, 2) in vitro mutagenesis either by 
error-prone PCR or by chain-shuffling, and 3)transformation back into yeast
8
.  However, our ultimate aim 
was to develop a new in vivo method for affinity maturation, and so we moved on after this initial proof of 
function to the development of the in vivo mutagenesis system described in Chapter 3. 
 The R38A mutant might be an interesting model system in the future for exploring evolution 
pathway divergence.  We choose to build our first loop libraries with the medium-affinity R38A clone 
simply because we needed some libraries to test and hypothesized that for a single round of mutation, it 
might be easier to obtain an improvement in a medium-affinity binder than in a high-affinity binder.  
Although Arg38 contributes significantly (ΔΔG = 2.2 kcal/mol) to the binding of HA4, it is “merely” a 
scaffold residue.  It was not mutated as a part of Wojcik’s library to produce HA4 since it is located 
outside of the solvent-exposed BC and FG loops that are typically targeted in monobody evolution 
experiments.  Rather, it is located within a β-strand in the framework region of the scaffold.  It turns out 
that, partly because of the Arg38 interaction with SH2, the HA4 monobody binds SH2 in an atypical way, 
with the SH2 domain pinched between the FG loop and the framework CDFG β-sheet region 
2,21
.   
By using HA4R38A as the starting point for affinity maturation, we are decreasing the 
monobody’s “preference” to bind in this pinching mode.  It is then interesting to ask if we could mature 
HA4R38A back to a high-affinity clone, but one that binds in the typical way.  In other words, can we force 
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protein binders to find alternative solutions (for example different epitopes) to the same target by taking a 
step back energetically and then proceeding with more affinity maturation.  This would be interesting to 
follow up on using the mutagenesis strategy developed in the next two chapters. 
There is almost overwhelming amount of choice available in the type of diversity to use in a 
protein library.  There are many different ways that you could encode diversity into a protein binder 
library.  Many parameters can be varied, such as the number of mutated residues within the scaffold of 
interest, the position of those residues relative to each other, the subset of the 20 amino acids that the 
mutated residues can possibly switch to, and even the probabilistic frequencies of mutation
*
.  As a 
general rule, the designer does not know which library design strategy will work best a priori, and different 
antigens will be targeted optimally by different libraries.   
The length of the loop libraries was one decision that was tricky. HA4’s BC loop is 10 residues 
long.  If we were only making slight differences to the amino acid sequence, e.g., only mutating 2 of the 
10 residues at a time, it would make sense to keep it at 10.  However the cassette mutagenesis strategy 
here completely replaces all the residues in the loop.   The loops in this library would be completely 
different in amino acid character and would have different interactions with the surrounding protein 
structure.  Wild-type 
10
Fn3 domains tend to have 6, 7, 8, or 9, so we utilized those lengths as defaults. 
Another parameter that must be chosen is the mutation profile.  Oligo synthesis companies can 
insert degenerate nucleotides into your product, as was used in this work.  These degenerate nucleotides 
represent a probabilistic mix of A,T,C, and G.  The letter ‘N’ is used to denote a position in the oligo which 
could be any of the 4; during the oligo synthesis an equimolar mixture (“machine mixed”) of all 4 
phosphoramidite building blocks is allowed to react with the growing oligonucleotide polymer, giving a 
theoretical 25%
†
 chance of any particular base being inserted.  Whole codons can be constructed in this 
way, e.g. NNN is the codon where any of the 64 codons is equally probably. 
In fact, even more advanced methods are available to more tightly define the library specificity.  
Oligonucleotide companies can use hand-mixed ratios of base reagents, instead of equimolar mixes, e.g., 
                                                     
*
 E.g., 40% of my library members will have Ala at position 23 mutated to a Trp, 30% will have it mutated 
to Tyr, 25% to Phe, and 5% will have it remain Ala 
†
IDT’s website claims that with the standard machine mixing option, skewing of the base ratios may occur 
due to “differences in delivery rate.”  
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80% A, 10% T, 7% C, 3% G.  As of this writing, an example 58-bp oligo with six hand-mixed nucleotides 
was five times as expensive as one using six machine-mixed nucleotides.  When building multiple 
different libraries, this cost quickly becomes burdensome.  An additional method
22
, utilizing trinucleotide 
phosphoramidite reagents, can be employed to tightly control the amino acid frequency by building the 
oligo up in trinucleotide chunks instead of nucleotide by nucleotide.  This method is also expensive.   
In this work, we chose to stick with standard degenerate codons, as this significantly reduces the 
cost, and thus gives our mutagenesis technology much greater appeal and applicability.  Given the 
observed bias in our library towards prolines, though, it is worth examining in the future where that source 
of codon bias arose from. 
 
2.5 Materials and Methods 
General molecular biology 
Standard methods for molecular biology in Saccharomyces cerevisiae and Escherichia coli were 
used
23
.  S. cerevisiae strains were grown at 30 °C in media containing 2% glucose unless otherwise 
noted.  Cells were incubated in a New Brunswick Scientific Series 25 Incubator Shaker.  Yeast cell 
density was determined by measuring optical density at 600 nm; OD = 1 was assumed to be a cell 
density of 1 x 10
7
 cells per mL for strains EBY100, ysMDM100, and all their derivatives.  Yeast 
electroporation was carried out using a previously reported protocol
24
 on a Bio-Rad Gene Pulser Xcell.  
Yeast were stored by mixing yeast culture 1:1 with sterile 30% glycerol, dispensing in cryo-tubes, and 
storing at -80 °C.  E. coli were stored long term by mixing liquid culture with 40% glycerol in a 1:1 
proportion in cryotubes and then putting the tubes in a -80 °C freezer.  E. coli transformation was carried 
out by electroporation using a Bio-Rad E. coli Pulser.   
All aqueous solutions were made with distilled water prepared from a Milli-Q Water System.  
Restriction enzymes and Vent DNA polymerase were purchased from New England BioLabs, GoTaq 
DNA polymerase was purchased from Promega.  dNTP mix was GE Healthcare illustra dNTPs purchased 
from Fisher Scientific.  MJ Research PTC-200 Pellier Thermal Cyclers were employed for PCR.  Plasmid 
DNA was purified from E. coli using QIAprep miniprep kits from Qiagen, for yeast minipreps, cells were 
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vortexed with acid-washed glass beads (Sigma) for five minutes before cell lysis.  PCR products were 
purified with agarose gel electrophoresis and QIAquick spin columns.  Agarose gels were run at 120-140 
V using a Bio-Rad PowerPac 100.  DNA was quantified using the UV absorbance at 260 nm on either a 
Molecular Devices SpectraMax Plus 384 instrument or a Tecan Infinite M200 with NanoQuant 
capabilities.  Ethanol precipitations of DNA were done with Pellet Paint from Novagen.  Plasmids and 
PCR products were eluted and stored in H2O or EB buffer (10 mM Tris-HCl, pH 8.5) at -20 °C.  Plasmid 
DNA was stored long-term by transformation into E. coli and then storing glycerol stocks of the cells at -80 
°C.   
All synthetic DNA oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, Iowa).  PCR primers were typically designed to be 18-24 bp in length, with a TM between 50 
and 60 °C, and a GC content between 45 and 55%.  TM’s were estimated on IDT’s website 
http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/ which uses the nearest-neighbor two-state 
model of oligo thermodynamics with parameters taken from SantaLucia et al
25
. 
Routine DNA sequencing was carried out by mixing template DNA with 25 pmol of PCR primer in 
a PCR tube, and sending this sample mixture to GENEWIZ, Inc. (South Plainfield, NJ, 
www.genewiz.com).  96-well plate sequencing was done in the lab of Dr. Jingyue Ju at Columbia or by 
sending the plate to GENEWIZ. 
 
Media and buffer recipes 
 PBS (aka loading buffer):  20mM PO4, 150mM NaCl, pH 7.4 
 PBSF buffer: Dissolve 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4,0.24 g KH2PO4 and 1 g bovine serum 
albumin in 1 liter of deionized H2O, adjust the pH to 7.4 and sterilize by filtration. This solution can 
be stored for up to 6 months at 4 °C (from Chao 2006). 
 FPLC wash buffer:  20mM PO4, 150mM NaCl, 40 mM imidazole, pH 7.4 
 FPLC elution buffer:  20mM PO4, 150mM NaCl, 500 mM imidazole, pH 7.4 
 SG media (500 mL) 
o 250 mL 2x SD 
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o 25 mL of 20X amino acid mix 
o 33.3 mL 30% galactose 
o 192 mL of ddH2O 
DNA Ligation 
Plasmids and PCR products were digested simultaneously by two different restriction enzymes 
(New England BioLabs) overnight.  Buffers, incubation temperature, and inclusion of BSA were chosen to 
maximize enzyme activity.  Double-cut DNA was purified through agarose gel electrophoresis, followed by 
band excision with a knife and gel extraction with Qiagen kit. 
Ligation reactions were carried out in 20 µL volumes: 1 µL of T7 DNA ligase, 2 µL of 10x ligase buffer, 
200-300 ng of digested plasmid, and X ng of insert, where X is chosen such that the molar ratio of insert 
to plasmid was between 10 and 30. The final volume was adjusted to 20 µL with ddH2O. The reagents 
were mixed in a PCR tube, and kept at 16 °C for 10 hours on a thermocycler. 
After this incubation, the reaction mix was pelleted with ethanol precipitation.  Aliquots of 
electrocompetent TG1 E. coli cells were removed from -80 °C storage, thawed on ice for 10 minutes, and 
then 50 µL of cells were added to the pelleted ligation rxn and mixed by pipette.  The cells were left on ice 
for an additional 10 minutes, transferred to an electroporation cuvette and then electroporated.  
Immediately after electroporation, the cells were resuspended in 1 mL of warm LB media and incubated 










Making polyacrylamide gels for SDS-PAGE 
10% gel (recipe below) was prepared and poured into gel cases. 500 µL isopropanol was added 
to smooth top of gel.  The gel was allowed to harden for 45 min.  The isopropanol was poured off and the 
the gel rinsed with ddH2O.  Stacking gel (recipe below) was prepared and added while inserting the lane 
comb in a chopping motion.  The stacking gel was allowed to solidify for another 45 minutes. 
 
 
E. coli colony PCR 
Colonies from an agar plate were picked up with pipette tips and suspended in 20 µL of H2O in a PCR 
well (optionally the pipette tips can then be used to patch a replica agar plate for further storage of the 
colony).  A PCR mix was made with 1 µL of 10 µM forward primer, 1 µL of 10 µM reverse primer, 0.5 µL 
of dNTP mix, 4 µL of 5x GoTaq Buffer, 3 µL of H2O, and 0.5 µL GoTaq polymerase (purchased from 
Promega).  10 µL of this PCR mix was added to 10 µL of the cell suspension and program EPP5 was run 
on the thermocycler.  Agarose gel electrophoresis was used for quality inspection of PCR products and 
for gel purification of bands.  Bands purified by Qiagen prep kit were sent to GENEWIZ for sequencing. 
 
Expression of GST-SH2 fusion protein 
Plasmid pGST-SH2 was obtained from the Koide Lab at the University of Chicago.  Competent 
BL21 DE3 E. coli cells were thawed from the freezer and added to the 2 µL of plasmid.  Transformation 
was carried out by electroporation.  Cells were grown on LB + kanamycin plates. 
The following protein expression protocol follows the auto-induction method of Studier, see his 
paper
6
 for all media recipes and protocol details.  A colony from the LB+kanamycin plates was inoculated 
10% Gel Stacking Gel 
ddH2O (mL) 2.47 4.94 9.88 14.82 ddH2O (mL) 3.2 6.4 12.8 19.2 
1.5 M Tris-Cl/SDS pH 8.8 
(mL) 
1.25 2.5 5 7.5 
5 M Tris-Cl/SDS pH 6.8 
(mL) 
1.25 2.5 5 7.5 
Acrylamide/Bis 40% (mL) 1.25 2.5 5 7.5 Acrylamide/Bis 40% (mL) 0.5 1 2 3 
10% APS (μL) 25 50 100 150 10% APS (µL) 25 50 100 150 
TEMED (µL) 3.75 7.5 15 22.5 TEMED (µL) 5 10 20 30 
Total Volume (mL) 5 10 20 30 Total Volume (mL) 5 10 20 30 
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into 5 mL P-0.5G media in a 25 mL flask, which was put shaking in 37 °C shaker overnight.  The following 
afternoon, the overnight culture was inoculated 1:1000 into ZYP-5052 auto-induction media (250 mL – 2L 
depending on amount of protein desired) and grown overnight at 30 °C.  The following morning, 20 μL of 
each flask was taken for SDS-PAGE.  The rest of the cultures were transferred to sterile centrifuge bottles 
(250 mL / bottle) and spun 10,000xg, 15 min, 4 °C on Beckman Coulter Avanti J-E Centrifuge.  The 
supernatant was poured off and the cells were resuspended in 40 mL of 20mM Phosphate buffer, 150mM 
NaCl with 5mM beta mercaptoethanol (pH 7.4) per 500 mL of original culture volume.  Resuspension was 
carried out by pipetting up and down until all the cells were thoroughly separated.  The resuspended cells 
were frozen at -20 ºC; this step helps break open the cell membranes. The cell pellet was thawed and 
PMSF was added to a final concentration of 1 µM.  Then hen egg lysozyme was added to a final 
concentration of 0.5-1 mg/mL and the cell suspension was mixed thoroughly by swirling.   The mixture 
was incubated at 37 °C 30 min.   
150 µL of cell lysate was pipette up and down to get a sense of the viscosity.  The cells were 
transferred to a glass beaker and sonicated (QSONICA Misonix S-4000) on ice at a power of 50 for 4-6 
cycles of 30 sec on, 30 sec off.  To verify that sonication had successfully lysed the cell membranes, 150 
µL of cell suspension was pipetted up and down, and compared to the pre-sonication viscosity.  The cell 
lysate should be watery (low-viscosity) at this point.  20 µL of this lysate was taken for SDS-PAGE.  The 
rest of the lysate was centrifuged at 30,000xg for 15 min at 4 ºC.  The supernatant was collected for 
column purification.  4 µL of 6X SDS was added to each 20 µL sample, and boiled on a hot plate for 10 
min (95 °C).  Samples were run on 10% polyacrylamide gels at 120 V for 1 – 1.5 hrs, with Precision Plus 
Protein™ Kaleidoscope™ standards from Bio-Rad. 
 
Purification of GST-SH2 fusion protein 
All affinity column purifications were performed on a GE Amersham Pharmacia Biotech 
AKTAFPLC (P-920 and UPC-900) using GE Histrap HP columns (1mL or 5 mL). 
10 column volumes of H2O were run to clear the storage liquid out of the system and the injection loop.  
Then 10 column volumes of PBS (20mM PO4, 150mM NaCl, pH 7.4) were run to equilibrate the column 
47 
 
and fill the injection loop.  The GST-SH2 supernatant was filtered through 0.22 µm Pall Acrodisc filters.  
Using a 12 mL syringe and an 20 g needle, 10 mL of filtered protein solution was slowly pulled up, so as 
to avoid formation of bubbles, and then loaded into the injection loop.  The protein solution within the loop 
was then pushed onto the column with 10 mL of loading buffer, collecting fractions as “flow-through.”  
Protein was eluted by running a linear gradient over 20 column volumes from 10% elution buffer to 100%, 
where elution buffer is 20mM PO4, 150mM NaCl, 500 mM imidazole, pH 7.4. 
 
Biotinylation of GST-SH2 
To remove the imidazole and reduce the cysteines with DTT, buffer exchange was carried out 
with Amicon spin filters with a molecular weight cut-off of 10,000 daltons. 
Clean fractions (as determined by SDS-PAGE) from column purification were combined into one protein 
solution.  DTT was added to the protein solution to a final concentration of 5 mM, this was mixed on a 
rotator for 10 min.  Then the protein solution was added to an Amicon filter pre-equilibrated with PBS.  
The solution was centrifuged at 3 krpm until concentrate was < 1 mL (roughly 90 minutes).  PBS with 5 
mM EDTA was added up to 15 mL.  Two more repetitions of centrifugation and dilution with PBS/EDTA 
were carried out.  Final protein concentration was then quantitated via A280 on a Molecular Devices 
SpectraMax Plus 384 instrument or a Tecan Infinite M200
26
.  Using the primary amino acid sequence and 
the ProtParam bioinformatics tool at ExPASy (www.expasy.org), the extinction coefficient of the translated 




, with molecular weight 43,100 g/mol.   
To make HPDP stock, 3.1 mg of  EZ-Link HPDP-Biotin (Thermo Scientific)  was added to 1 mL 
DMSO in a glass vial for a final concentration of 5.6 mM.  1.25 mL of SH2-GST solution from spin filter 
and 100 µL of HPDP stock were combined in a microfuge tube, and put rotating at RT for 2 hrs.  Using a 
fresh spin filter or dialysis, the unreacted HPDP reagent was buffer exchanged away with 3x 15 mL of 
PBS.   
Quantitation of biotin was carried out using a Pierce Biotin Quantitation Kit (Thermo Scientific).  
800 µL of PBS was added to a cuvette.  This was used to blank a spectrophotometer at wavelength 500 
nm.  100 µL of a mixture of 4'-hydroxyazobenzene-2-carboxylic acid (HABA) and avidin were added to the 
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cuvette, and an absorbance measurement at 500 nm was taken as a starting point for the assay.  To start 
the assay, 100 µL of biotinylated GST-SH2 was added to the cuvette.  Every ten seconds, an absorbance 
measurement was taken.  When the absorbance reading was the same for at least 30 sec, that reading 
was taken as the endpoint and used to calculate the molar ratio of biotin  
 For storage, the biotinylated GST-SH2 was aliquoted into individual microfuge tubes and flash 
frozen in liquid nitrogen, and then stored at -80 °C. 
Galactose Induction of Yeast Display 
The library of cells was grown in selective SC media to OD600 between 1 and  3.  The desired 
number of cells for selection was transferred to a 50 mL conical tube and spun down 15 min at 2800xg.  
The supernatant was poured off by a sterile flame, and the cells were resuspended in selective SG media 
to a final OD between 0.5 and 1.  The conical tubes were then put on a rotator at 23-25 °C for 20-36 hrs. 
 
 
Magnetic Bead Capacity Experiment 
I subcloned the HA4 and HA4R38A genes into the yeast display vector within EBY100 cells by 
gap-repair.  For the purpose of having a strong positive control, I obtained from the Wittrup lab a yeast 
display plasmid (pCT-L7.5.1) for a fibronectin binder (L7.5.1) with Kd = 3 pM and transformed this into 
EBY100, as well
8
.  The target of binding of L7.5.1 is lysozyme, and Lysozyme Biotin-Caproyl was 
purchased from Sigma-Aldrich.   For a negative control, I transformed pGalR38A, which has a non-sense 
stop codon in the middle of the BC loop, into EBY100, to make ysEBYR38A*. 
Dynabeads M-280 streptavidin-coated beads and magnetic rack (MagnaRack CS15000) were 
purchased from Invitrogen.  Settled beads stored at 4 °C were resuspended by vortexing 2-5 sec, and 10 
µL of bead suspension (5x10
6
 beads) were transferred to individual 1.5 mL microfuge tubes and washed 
3x with 1 mL PBSF using the magnetic rack to separate beads from supernatant.  The beads were coated 
with 100 µL of 36.7 pmol biotinylated target, either GST-SH2 for ysEBYHA4 or lysozyme for ysEBYL751, 
and then left rotating overnight at 4 °C. 
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SC dropout cultures of strains ysEBYHA4, ysEBYL751, and ysEBYR38A* were grown to 
saturation (OD600 = 3 – 4).  On the day before selection, 25 mL of culture were transferred to 50 mL 
conical tubes and centrifuged 2800xg for 10 min.  The supernatant was poured off, and the cell pellets 
were resuspended in 25 mL of SG dropout media.  These induction cultures were put on the rotator for 24 
hrs at 23 °C.   
On the day of selection, 5x10
8
 cells were taken from each galactose induction culture and spun 
down 2800xg for 5 min, and the supernatant poured off.  In a cold room maintained at 4 °C, the beads 
were pulled down magnetically and the supernatant pipetted off.  The beads were washed 2x with 1 mL 
cold PBSF in the same manner.  The galactose-induced cells were resuspended in 1 mL cold PBSF and 
added to the target-coated beads in the microfuge tubes.  The cell-bead mixtures were put on the rotator 
at 4 °C for 2.5 hrs. 
 After this incubation, the tubes were put on the magnet for 5 min.  The sup was pulled off and 
dilution plated on SC(UT-) dropout plates to determine # of cells not bound to beads.  The beads were 
washed 4x with 1 mL cold PBSF.  The beads were then resuspended in 1 mL PBSF and dilution plated 
on SC(UT-) to determine # of cells bound to beads. 
 
Magnetic Bead Mock Library Enrichment 
Galactose inductions were carried out as above; SG(UT-) media was used for strains ysEBYHA4, 
ysEBYL751, ysEBYR38A*, and SG(U-) media for strain EBY100 (containing no display plasmid).  2.5 x 
10
6
 magnetic beads were labeled overnight at 4 °C as above. 
 On the day of the selection, 5x10
5
 cells of each monobody display strain were mixed with 5x10
8
 
EBY100 (background) cells immediately prior to adding the cells to the washed magnetic beads.  Dilution 
plates were made at this point to determine the pre-selection library ratio, with SC(U-) plates for growth of 
all cells and SC(UT-) plates for growth of cells containing display plasmid.  The library-bead mixtures 
were than rotated at 4 °C for 2 hrs 40 min  After rotation, the beads were washed 4x with 1 mL cold 
PBSF.    The beads were resuspended in 1 mL PBSF and dilution plates were made to determine the 




Flow Cytometry of ysEBYHA4 
7.7 μL bead slurry (5 x 10
6
 magnetic beads) were added to each tube, washed 2x with PBSF and 
incubated with 100 µL of 367 nM GST-SH2 overnight.  10
6
 ysEBYHA4 and EBY100 cells from galactose 
induction were centrifuged at 14 krpm for 1 min.  The cells were washed once with 1 mL PBSF, and then 
resuspended in 50 μL of 23.4 nM SH2-GST-Biotin and then put in the cold room to rotate for 3.5 hrs.  The 
rest of the steps were done on ice.  The cells were pelleted by spinning 30 sec @ 14,000 rpm.  
Supernatant was pipetted off and the cells were washed with ice-cold 1 mL PBSF.  Cells were then 
resuspended in 50 μL of PBSF, to which 0.5 µL of FITC-anti-V5 and 0.5 µL of PE-streptavidin were 
added.  These were rotated at 4 °C for 10-20 min.  The cells were then spun 30 sec @ 14,000xg and 
washed with ice-cold 1 mL PBSF.  The supernatant was removed and the cell pellets were left on ice 
during physical transit to the flow cytometry core at Columbia University Medical Center.  Immediately 
prior to cytometry, the cell pellets were resuspended in 500-800 μL of cold PBSF.  Cytometry 
measurements were made on a BD FACSCanto analyzer. 
 
Construction of yeast display plasmid for homologous recombination experiments 
The backbone for yeast display is the pYD1 plasmid, and the yeast strain used is EBY100.  The 
earliest libraries were created by gap-repair.  In gap-repair editing of plasmids, the backbone plasmid is 
first linearized with restriction enzymes, ideally with the cut site being in the center of the DNA region you 
wish to edit.  An insert is produced by PCR or polymerase extension of synthetic oligonucletides such that 
both ends of the insert have homology (generally > 30 bp) to the plasmid on both sides of the cut site 
made above.  The insert and the cut plasmid are then co-transformed into yeast.  Once inside the cell, the 
yeast homologous recombination machinery replaces the cut DNA in the plasmid with the insert, and in 
doing so, re-circularizes the plasmid. 
I knew early on that I wanted to utilize homologous recombination to replace one of the 
10
Fn3 
loops with a loop library.  In order to assess the success of the technology as I developed it, I wanted to 
build a plasmid that would be non-functional until homologous recombination with my libraries took place.  
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Furthermore, I wanted the process of homologous recombination to remove a unique cut-site; the 
presence of cutting discernable on an agarose gel could then serve as a diagnostic of whether 
recombination took place or note.  To accomplish both of these goals, I created pGalEng (for engineered 
BC loop), an 
10
Fn3  displaying vector where the wt BC loop was replaced with one containing a non-
sense stop codon and a ClaI cut site; I call the resulting sequence the “template” BC loop.   
Since I had used pGalAgaFNC as the backbone, I now had a hybrid 
10
Fn3 gene with the N-
terminal part from HA4R38A, the template BC loop, and the wild-type fibronectin C-terminus.  To finish, I 
had to subclone the C-terminal part of HA4R38A into pGalEng.  This gave me pGalR38A, which was the 
starting point for my library mutations. 
pGalEng was constructed by first digesting pGalAgaFNC (a gift from the Koide Lab) with NheI 
and EcoRI.  A 5’ insert fragment was made by PCR of the pHFT2-R38A plasmid with primers MDM0015 
and MDM0013, and a 3’ insert fragment was made by PCR of pHFT2-R38A with primers MDM0025 and 
MDM0023.  The linearized pGalAgaFNC and the two insert fragments were all co-transformed into yeast, 
with gap-repair resulting in the desired product. 
To construct pGalR38A, primers MDM0055 and MDM0053 were used to PCR the C-terminal end of the 
HA4R38A gene in pHFT2-R38A.  pGalEng was digested at a single site with SacI, and the digested 
enzyme was co-transformed with either the HA4 C-terminal insert or the R38A insert into yeast, where 
gap repair by homologous recombination yielded the final product. 
Sequencing of 
10
Fn3 in pGalEng and in all later yeast display vectors was carried out with oligos 
MDM0035 and MDM0032. 
The χ
2
 test on 8x NNB library was performed using 18 bins (the six categories with predicted freq. 






Construction of mutagenic BC cassettes 
The construction of the BC loop libraries is illustrated in Figure 2-X.  These libraries were constructed by 
overlap extension PCR.   
 
The reaction was carried out in a single PCR reaction, for which the recipe was: 
1 µL of 100 µM oligo 1 (MDM0041) 
1 µL of 100 µM oligo 3 (MDM0043) 
1 µL of 10 µM oligo 2 (either one of or a mixture of the following oligos) 
 MDM042-2 for 6 NNB codons 
 MDM042-1 for 7 NNB codons 
 MDM0042 for 8 NNB codons 
 MDM042+1 for 9 NNB codons 
 MDM045-2 for 6 NNY codons 
 MDM045-1 for 7 NNY codons 
 MDM0045 for 8 NNY codons 
 MDM045+2 for 9 NNY codons 
1 µL of dNTP mix 
5 µL of 10x pfu buffer 
40.5 µL of ddH2O 
Figure 2-8.  Construction of mutagenic 
BC cassettes by oligonucleotide 
extension PCR.  Each rectangle 
represents a single-stranded stretch of 
DNA.  The stretch of randomized 
codons is shown in yellow.   
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0.5 µL of PfuTurbo DNA polymerase (from Stratagene) 
The thermocycler program was: 
 
The Koide Lab at the University of Chicago sent us pHFT2 plasmids containing the 
10
Fn3 mutants HA4 
(Kd = 10 nM), HA4R38A (Kd ≈ 350 nM), and the Abl1 SH2 domain.  The pHFT2 vector is based on pET, 
contains a kanamycin resistance gene, an N-terminal 10-His tag cleavable with TEV protease.   
 
FACS sorting of libraries 
FACS was carried out as above for ysEBYHA4.  After galactose induction of libraries, 7.5 x 10
7
 cells from 
each library were spun down, washed with 1 mL PBSF, and then resuspended in 1 mL PBSF.  Sorting 
was carried out on a BD Influx
TM
 cell sorter. 
 
Yeast Transformation 
The night before electroporation, yeast cells were inoculated from a fresh patch onto a culture 
plate in 5 mL of selective complete (SC) medium.  Shook cells at 30° C O/N 
Put 100 mL of YPD in separate flask and warm in shaker O/N, as well 
The next morning, the OD600 of a 1/10 dilution of O/N culture was determined.  The O/N culture 
was inoculated into 100 mL of YPD to an OD=0.1 The cells were grown in a 30°C shaker until 
OD600≈0.6-0.8 (usually after 4-5 hrs.). 
Transformation DNA was distributed into 6 different microcentrifuge tubes and pelleted. 
 Tube 1: no DNA 
 Tube 2: cut vector only, 0.5 μg 
 Tubes 3-6: 3 μg cut vector + 10 μg library PCR fragments (Wittrup) 
1ml of filter-sterilized 1,4-dithiothreitol (DTT) solution (1M Tris, pH 8.0, 2.5M DTT) was added to the 
100ml of YPD. The cells were allowed to grow for another 20 min at 30°C.   The Tris was prepared ahead 
of time, and then the DTT was added to the Tris right before adding it to the YPD. 
From this point, the cells were kept on ice. The cells were centrifuged at 5min, 2000rpm, 4C, in 
50ml falcon tubes.  The supernatant was discarded and the cells were washed with 25ml of cold E buffer 
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(10mM Tris, pH 7.5, 270mM sucrose, 1mM MgCl2) by pipetting up and down.  The cells were spun down 
again, with the supernatant discarded, and the cells were resuspended in 1ml of E buffer and transfered 
to a 1.5ml microcentrifuge tube and spun down again (10sec total, 12000rpm).  The supernatant was 
discarded and the cells were resuspended with 50 μl E-buffer. Distributed 50 μL cells into each of the 6 
microcentrifuge tubes containing the pelleted DNA.   
The cells and pelleted DNA were mixed by pipetting until the pellet was no longer visible, and 
then the mixture was allowed to sit for 10 min on ice.  The electroporator was set to 25 μF, 540 V, 0 
ohms. The cells were transferred to a 0.2cm eletroporation cuvette and pulsed. Immediately after 
electroporation, 1ml warm YPD was added to the cells, which were then shook at 30ºC for 1hr.   
After incubation, the cells were transfered to microcentrifuge tubes and spun at 10k rpm for 10 
sec at R.T.  The cell pellets were resuspended in 200 μL of sterile water.  Tubes 1 and 2 (negative 
controls) were plated on selective media to determine degree of background growth.  Tubes 3-6 were 
pooled and and transfer to 200 mL of selective media.  8 μL of this mixture was removed for dilution 
plating to determine library size.  The liquid cultures and plates were incubated at 30 °C for 2 days 
After incubation, colonies on plates were counted to determine library size and background 
growth rate.  The 200 mL culture was centrifuged at 3000 g for 5 min and supernatant was discarded.  
The cells were resuspended in 200 mL sterile water.  Centrifuge was carried out again at 3000 g for 5 
min.  The cell pellets were resuspended in 7.5 mL sterile water, and 5 µL were taken to make a 200x 
dilution for OD600 determination.  OD600 = 1  10
7




 cells/mL (A600 = 100-
1000) are expected.  Glycerol stocks were then made using at least 20X library size per tube. 
 
Yeast Colony PCR 
The following is adapted from a protocol from the Hahn Lab: 
http://labs.fhcrc.org/hahn/Methods/mol_bio_meth/pcr_yeast_colony.html 
Colonies from a media plate were picked up with a pipette tip or inoculating loop and suspended in 30 µL 
0.2% SDS in individual PCR tubes.  The SDS suspensions were vortexed on high for 30 sec, and then 
the PCR tubes were heated to 95 °C for 5 min on a thermocycler.  The tubes were then spun on a 
55 
 
centrifuge @ 2800xg for 5 min.  0.5 µL of the supernatant was added to a 50 µL total PCR reaction mix, 
which also included 0.5 µL dNTP mix, 0.5 µL MDM0035, 0.5 µL MDM0032, 10 µL of 5x GoTaq Buffer, 
37.5 µL of H2O, and 0.5 µL of GoTaq DNA polymerase. 
This reaction was cycled 25 times, with 54 °C annealing temperature.  After thermocycling, the PCR 
products were purified by agarose gel electrophoresis followed by gel extraction with a QIAquick Gel 
Extraction kit (Qiagen).  Alternatively, if high throughput number of colonies were being sequenced, the 
PCR reaction would be purified enzymatically by adding 1 µL of ExoSAP-IT to 9 µL of PCR reaction 
followed by 15 min incubation at 37 °C, then 15 min incubation at 80 °C.  With either method, 10 µL of 
purified PCR product were mixed with 5 µL of 5 µM PCR primer and sent to GENEWIZ for sequencing. 
2.6 Strains, Plasmids, and Oligonucleotides 
Table 2-7.  Strains used in this study 
Name Details Source/Reference 
EBY100 MATa ura3-52 trp1 leu2Δ1 his3Δ200 
pep4:HIS3 prb1Δ1.6R can1 GAL yeast 




ysEBYHA4 EBY100 containing pYD-HA4  
ysEBYL751 EBY100 containing pCT-L7.5.1  












Table 2-8.  Plasmids used in this study 
Name Details Source/Reference 
pYD1 pUC-ori PGAL1 TRP1 CEN6/ARSH4 amp
R
  Koide Lab 
pGalAgaFNC pUC-ori PGAL1 N-term 
10
Fn3 TRP1 CEN6/ARSH4 amp
R
  Koide Lab 
pGST-SH2 GST-SH2 fusion protein under T7 lac promoter kan
R
 Koide Lab/1 
pGalEng pGalAgaFNC with template BC loop (ClaI and stop)  
pGalR38A pYD1 containing full HA438A with template BC pGalEng 
pYD-HA4 pYD1 containing HA4 monobody  
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A recombination system for in vivo mutagenesis 
 
3.1 Abstract 
In order to create libraries through in vivo mutagenesis, we need to have a system that can transfer 
genetic material from a cassette plasmid to a target plasmid through homologous recombination.  Here, 
we describe the construction of the three plasmid components and the editing of the yeast genome in 
order to effect efficient cassette-based mutagenesis.  Assays for homologous recombination demonstrate 
genetic conversion of the DNA encoding the BC loop in the monobody gene.   A timecourse induction 
with doxycycline showed that significant levels of homologous recombination are detectable after 3-4 
days of induction under a strong tetO7 promoter.  Finally, induction and selection of mock libraries 
demonstrated that recombinants could be enriched by magnetic beads, suggesting that their reconstituted 
HA4 monobody was functional. 
3.2 Introduction 
The main objective of the work described in this chapter was to build and assemble the genetic 
components required for in vivo mutagenesis, and then to confirm that DNA from a cassette plasmid was 
being successfully recombined into the yeast display plasmid.   
Because plasmids can be passed from one cell to another by mating, such a system would allow us to 





The key to our mutagenesis system is the use of homologous recombination to replace DNA in a 
target gene with a mutant sequence obtained from a separate plasmid.  Our strategy for accomplishing 
this mutagenesis requires a 3-plasmid genetic system (Figure 3-1).  One plasmid contains the monobody 
gene and is responsible for expressing the monobody protein on the surface of the yeast.  A second 
plasmid contains the mutagenic DNA cassette.  A third plasmid expresses an endonuclease which 
generates double-stranded breaks (DSB’s) in the DNA.  Ideally, we wish to have a system such that any 
yeast cell containing both our template plasmid and our cassette plasmid will rapidly and accurately 
replace the sequence of interest in the template plasmid with the mutant sequence from the cassette 
plasmid.   
  To drive homologous recombination (and thus mutagenesis in our system), we needed to 
introduce double-stranded breaks (DSB’s) into the DNA in vivo
5
.  Saccharomyces cerevisiae is very 
efficient at repairing double-strand breaks (DSB’s) using homologous DNA
6,7
.  They have a complex 
assortment of cellular machinery for detecting and fixing DSB’s
8,9
.  These proteins are responsible for 
processing the cut DNA ends and searching through all of the DNA in the nucleus for sequence 
homology.  Both the yeast chromosomal genome and any plasmids that happen to be present in the 
nucleus can be potential donors of homologous DNA.  Once homologous DNA is found, the 
Figure 3-1.  A three plasmid system for in vivo mutagenesis.  The wild-type monobody gene 
(yellow) is contained within the yeast display plasmid, T.    An endonuclease is encoded on a 
second plasmid, E.  A DNA cassette is contained on a third plasmid, C.  The cassette contains a 
mutant sequence (green) for replacing a wild-type sequence in the monobody, flanked on both 
ends by homologous DNA which allows the cassette to be targeted to the monobody gene on 
plasmid T.  Induction of the endonuclease enzyme (blue pacman) followed by double-strand 
break formation and homologous recombination results in a mutated display plasmid T where 
the wild-type DNA has been replaced by the cassette.  The resulting protein monobodies are 
show expressed on the cell surface (yellow and green floret). 
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recombination machinery aids a DNA polymerase in repairing the DSB through new DNA synthesis, using 
the homologous sequence from the donor as a template. 
We chose to use the I-SceI enzyme to generate the DSB’s in vivo. I-SceI is an endonuclease that 
is expressed naturally in the yeast mitochondria.  It generates DSB’s at highly specific 18 bp recognition 
sequences
10
.   Plessis et al. demonstrated that I-SceI expressed from a plasmid could be active in the 
yeast nucleus and catalyze double-strand breaks at its specific cut-site
4
. 
The basic idea (outlined in Chapter 1, Figure 1-3) is as follows.  We use the highly specific I-SceI 
endonuclease to make a double-stranded break (DSB) immediately adjacent to a mutagenic cassette.  
The yeast homologous recombination machinery is recruited to this cut.  The homologous region next to 
the cut is then used to target the cassette to the monobody gene in the yeast display plasmid.  
Homologous recombination results in the conversion of the existing BC loop sequence in the display 
plasmid to the mutant sequence encoded by the cassette plasmid.  Induction of yeast display with 
galactose puts this mutated protein variant on the surface of the yeast, and phenotypic selection by 
magnetic beads or FACS allows us to isolate the cells with the most functional mutants.  These high-
functioning yeast can then be mated with a library of yeast containing a different FG loop variants, 
resulting in a mixing of mutagenic cassette plasmids which target the two different loops. 
 
3.3 Results and Discussion 
Construction of diagnostic yeast display plasmid 
  We built a yeast display plasmid that contained the HA4 gene with a mutated BC loop.  This 
plasmid (named pHRS-YD1B) contains a BC loop that was intentionally altered from the HA4 BC in 3 
ways: 1) its sequence is DASMTWLSV* where * is an Amber TAG stop codon, 2) it contains a ClaI cut 
site, and 3) it lacks a flanking BsiWI cut site (Figure 3-2).  The purpose of pHRS-YD1B and its 
“placeholder” BC loop is to serve as a diagnostic for whether homologous recombination with the 
mutagenic cassette has taken place or not.  The fixing cassette (in the cassette plasmid) was designed to 
replace this placeholder BC loop with the wild-type HA4 BC sequence (DAPMSSSSVY), which 1) fixes 
the stop codon, 2) removes the ClaI site, and 3) adds a BsiWI site.  Because a V5 epitope tag is located 
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C-terminal to the monobody, labeling with fluorescent anti-V5 antibody followed by flow cytometry 
enables us to differentiate between cells with unrecombined plasmid (stop codon) and cells with 
recombined plasmids (expressed V5).  This was all intended so that I would be able to detect 




Plasmids for inducible expression of I-SceI endonuclease and DSB’s 
 The gene coding for the I-SceI endonuclease was cloned into CEN plasmids under the control of 
the reverse tetracycline inducible expression system
11,12
.  Under this system, addition of doxycycline to 
the cell medium activates expression of I-SceI.  We chose such an inducible expression system because 
we only want DSB’s to be formed during a well-defined induction time.  Constitutive expression of I-SceI 
would be expected to lead to genetic instability of the cassette plasmids.  Additionally, the constant 
presence of DNA DSB’s would be expected to slow growth of cells via cell cycle arrest
13
, which could 
result in significant growth biases within a population of cells.  
 The strength of the activation depends upon the number of regulatory tetO boxes present 
upstream of the I-SceI gene.  We cloned the I-SceI gene into two expression plasmids with promoters of 
different strength.  Plasmid pHRS-Sce1 expresses I-SceI under the weaker tetO2 promoter (two tetO 
boxes) whereas pHRS-Sce2 expresses I-SceI under the stronger tetO7 (seven tetO boxes).  
 
Figure 3-2.  BC placeholder in pHRS-YD1B has diagnostic features.  Yeast display plasmid pHRS-YD1B 
contains a modified HA4 gene (scaffold framework regions in teal, loop regions in blue).  A stop codon 
has been added to the BC so that unrecombined plasmids produce a truncated protein on the yeast 
surface without the downstream V5 epitope. A ClaI cut site has been added (scissors) and a BsiWI cut 
site has been removed with a silent mutation (crossed out scissors).  Thus unrecombined plasmid cuts 
with ClaI and doesn’t cut with BsiWI. 
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Replacing HIS3 with KanMX in the genome of EBY100 
Most yeast-display projects use the EBY100 strain of yeast first developed by Boder and 
Wittrup
14
.  It was derived from BJ5465 (a ura3-52 trp1 leu2Δ1 his3Δ200 pep4::HIS3 prb1Δ1.6R can1 
GAL)
15
.  EBY100 and its derivatives utilize a HIS3 insertion into the PEP4 locus in yeast chromosome XVI 
to give a functional knock-out of protease activity
15
.  However, for our purposes, this is a bit of a waste of 
a perfectly good marker, as selectable markers like HIS3 are the primary means by which yeast 
geneticists can ensure that their designed plasmids are present in their strain constructions
16
.  However, 
the number of auxotrophic markers that work well (low false positive background) are limited.  The four 
genes HIS3, LEU2, TRP1, and URA3 are robust plasmid markers, and selection is readily done using 
yeast dropout media
17
.  In our genetic system, URA3 is used to maintain the AGA1 gene under control of 
the GAL promoter in the chromosome.  Since this integrative plasmid has a certain frequency of splicing 
itself back out of the genome, the URA3 marker was necessary to ensure yeast display function.  TRP1 
and LEU2 were already being used to select for the yeast display plasmid and cassette plasmid, 
respectively.  Without HIS3 available, we would have had to utilize a sub-optimal alternative for the I-SceI 
plasmid.  To free up HIS3, we replaced the HIS3 in PEP4 with a KanMX module, which confers 
resistance to the G418 antibiotic
18
, effectively replacing the selection for growth on His- media with an 
antibiotic resistance selection.  Thus the PEP4 locus would remain disrupted, but we would be  able to 
use the HIS3 gene as a selectable marker for the I-SceI plasmid. 
 The genomic sequences flanking the PEP4 locus were obtained from the Saccharomyces 
Genome Database and used to design PCR primers.  PCR was used to amplify the KanMX module with 
flanking homology to the PEP4 locus (Figure 3-3).  This cassette was transformed into EBY100 yeast., 
followed by homologous recombination, would result in complete removal of HIS3 and any residual PEP4, 





 Transformants were plated on G418 plates (Figure 3-4a).  Compared to the negative control, the 
many transformants clearly acquired G418 resistance.  Individual colonies were taken from the G418 
plates and then patched onto SC(HU-) and SC(U-) plates to check for inability to grow on H-.  If indeed 
the pep4::HIS3 was replaced by KanMX, then the successful transformants should not grow on SC(HU-) 
plates.  Such colonies were found (Figure 3-4b), indicating that it possessed G418 resistance but no 
longer could grow on His- media.  This strain was named ysMDM100. 
Figure 3-3.  Chromosomal replacement of pep4::HIS3 by homologous recombination.  Yeast 
chromosome XVI in strain EBY100 is shown in purple.  An insertion cassette was created by PCR, 
containing the geneticin-resistance marker KanMX (blue) and flanking homology regions (teal).  
Recombination removes pep4::HIS3, maintaining the functional knock-out of pep4 while also freeing up 




Plasmids containing mutagenic cassettes flanked by I-SceI cut sites 
To test the ability of the in vivo mutagenesis to effect mutagenesis, we constructed cassette 
plasmids that contained either the functional HA4 BC loop sequence or the placeholder BC sequence.  
The mutagenic cassettes (Figure 3-5) were constructed by PCR.  We chose to make the homology 
regions 60 bp in length based on previous work that had thoroughly characterized the relationship 
between the length of flanking homology regions and the recombination efficiency of cassette insertion
21
.  
40 bp of homology on both sides was required for high recombination efficiency (> 90%), and diminishing 
returns were observed for homology > 60 bp.   
 
Figure 3-4.  Gain of KanMX, loss of HIS3 marker in yeast transformants. 
a, G418 antibiotic plates.  Growth is observed on the top two plates, which were 
spread with EBY100 cells transformed with the KanMX insert.  No colonies are 
seen on the bottom plate, which was spread with control EBY100 cells transformed 
with no DNA.  Individual colonies were taken from G418 dilution plates and plated 
on SC(U-) and SC(HU-).  b, an example of one such colony, where growth is 






 These cassettes were cloned into pRS425 plasmids via ligation, resulting in pHRS-Cas2 
containing the HA4 BC loop sequence.  pRS425 belongs to the YEp class of 2µ vectors
16
 which allows for 
high transformation efficiency and multiple copies of plasmid per cell.  This decision was based primarily 
on the fact that the pRS420 series of plasmids
17
 are maintained in their host yeast cells at 10-30 copies 
per haploid yeast cell
19
.  We reasoned that having multiple copies of the cassette plasmid in each cell 
would mean there would be multiple copies of the cassette that could potentially undergo homologous 
recombination with the binder DNA on the display plasmid.  The higher the copy number of the cassette 
plasmid, the higher the frequency of homologous recombination would be.  Romanini’s work showed that 
high copy cassette plasmids were viable and free of mutation even after induction of I-SceI cutting
20
.  
Furthermore, it wasn’t clear whether the process of generating cassettes would use up or destroy the 
cassette plasmid involved, so it might be required for additional copies of a given cassette plasmid to be 
present in order to pass the genetic information onto offspring cells. 
 
Assays for I-SceI induced homologous recombination 
 ysD2BC2S2, was made by co-transforming pHRS-YD2B (HA4), pHRS-Cas2 (HA4 cassette), and 
pHRS-Sce2 (strongly promoter I-SceI) into ysMDM100.  This strain was a positive control strain because 
both the yeast display plasmid and the cassette plasmid contained the functional HA4 BC sequence.  
ysD1BC2S2, was made by co-transforming pHRS-YD1B (HA4 with placeholder BC), pHRS-Cas2 (HA4 
Figure 3-5.  Cassette designed to target  a monobody loop for mutagenesis.  The mutagenic sequence 
(green) is flanked on both sides by homology regions (tan), which target the mutagenic sequence to the 
appropriate location within the monobody gene in the yeast display plasmid.  The homology regions are 
themselves flanked by recognition sites for the I-SceI endonuclease.  DSB formation recruits the yeast 
recombination machinery to the end of the homology region, enhancing the efficiency at which the 
cassette is targeted to the monobody gene. 
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cassette), and pHRS-Sce2 (strongly promoter I-SceI) into ysMDM100.  This was the experimental strain; 
the non-functional BC loop in the yeast display plasmid could only be fixed by recombination with the BC 
loop in the cassette plasmid.   
 The first assay for homologous recombination that we developed was based on a differential PCR 
reaction (Figure 3-6).  Two sets of primers were designed, with one set optimized to prime from the 
unrecombined (placeholder) BC DNA sequence, and the other set optimized to prime from the 
recombined (HA4) sequence.  The 5’ primer in both sets was designed to bind within the BC loop.  The 3’ 
primer was designed to bind further downstream, far enough that PCR could only take place using the BC 
loop in the yeast display plasmid and not the BC loop contained within the mutagenic cassettes also 




Figure 3-6.  A PCR assay to detect homologous recombination of the BC loop.  a, One 
set of primers (red) is designed to bind to the functional HA4 BC loop (green).  b)  A 
different set of primers (dark blue) is designed to bind to the template BC loop (black).  





 We first did a control experiment to see if this assay could distinguish between cells containing an 
unrecombined BC loop and cells containing a recombined HA4 BC loop sequence.   
Colony PCR was carried out with cells from both strains ysD2BC2S2 and ysD1BC2S2.   
The results are shown in Figure 3-7.  As designed, strong, clean PCR products were obtained when the 
primer set matched their intended target.  When the primer sets were used on the alternative BC 
sequence, the resulting PCR patterns on the gel were visually distinct, with multiple weak bands at 
incorrect gel distances.  In this way, the homologous recombination state of the BC loop can be observing 




Figure 3-7.  PCR assay can distinguish placeholder BC from HA4 BC.  In the case 
of cells being PCRed with the matching primer set (lanes 2 and 5), a single, strong 
band is produced.  In the case of cells being PCRed with the non-matching primer 
set (lanes 3 and 4), weaker, non-specific bands are observed.  “Place primer” 
denotes reactions where the PCR primers were designed to bind to the placeholder 


















Doxycycline timecourse for induction of homologous recombination 
Having verified the differential PCR assay’s ability to distinguish HA4 BC loop sequences from 
unrecombined placeholder BC sequences, we then tested to see if doxycycline induction of I-SceI 
expression could lead to conversion of a placeholder BC to HA4 BC in vivo.  We didn’t know a priori what 
length of time would be optimal for the doxycycline induction, so this experiment was performed as a time 
trial.   
 The experimental strains had I-SceI expressed under either a weak TetO2 (ysD1BC2S1) 
promoter or a strong TetO7 promoter (ysD1BC2S2).  The positive control strain ysD2BC2S2 was run 
alongside as a PCR control.  Doxycycline was added to cell cultures at OD600 = 2 to a final concentration 
of 1 µg/mL.  The cells were kept shaking up to seven days with the doxycycline.  Cells were removed at 
various timepoints, and colony PCR with the differential primers was used to produce the diagnostic PCR 
products (Figure 3-8).  Before addition of doxycycline, only the positive control gave a specific PCR 
product.  After 3 days, the cells with I-SceI expressed under the strong promoter had a distinct PCR 
product.  By about 4 days, the cells with the weak promoter have a noticeable band, and after 7 days, 
both strains yield a well-defined PCR product. 
 
 
Pre-Ind 24 hr 75 hr 95 hr 168 hr 
S + W S + W S + W S + W S + W S + 
O/N 
W 
Figure 3-8.  Increased homologous recombination with longer doxycycline 
induction.  Duration of cell exposure to doxycycline is given along the top, 
O/N are cells from the overnight culture prior to addition of doxycycline, 
and Pre-Ind are cells taken immediately prior to the addition of 
doxycycline.  W = ysD1BC2S1 (I-SceI expressed by weak TetO2 
promoter), S = ysD1BC2S2 (I-SceI expressed by strong TetO2 promoter), 




Western blot of I-SceI expression 
Protein expression of the I-SceI endonuclease under both the tetO2 and tetO7 promoter system was 
analyzed by western blot.  The I-SceI protein was labeled by its N-terminal FLAG tag (Figure 3-9).  The 
following strains were analyzed: (numbers correspond to gel lanes in figure) 
3. Haploid, TetO2 promoter, uninduced  
4. Haploid, TetO2 promoter, induced 22 hrs with doxycycline 
5. Haploid, TetO7 promoter, uninduced  
6. Haploid, TetO7 promoter, induced 22 hrs with doxycycline 
7. Diploid, TetO7  promoter, induced 22 hrs with doxycycline  
Both the diploid TetO7 and the haploid uninduced TetO7 appeared to be producing soluble protein that 




Mock libraries to determine recombination efficiency 
The assay up to this point has provided evidence of successful recombination at the DNA level.  It 
still remained for us to demonstrate that the recombinants had actually reconstituted functional HA4 which 
could be expressed on the surface and used in enrichments.  ysD1BC2S2 (called “C2” in this experiment) 
was used as the experimental strain, as it was in the assays described above.  For a negative control, a 
strain was constructed (ysD1BC4S2 or “C4”) which possessed a cassette plasmid that contained the 
same non-functional placeholder BC that the yeast display plasmid had.  Even if homologous 
recombination were to take place in C4, it would not produce a functional binder.   
The overall idea is illustrated in Figure 3-10.  C2 and C4 are mixed in different ratios.   
Figure 3-9.  Western blot analysis of I-SceI expression under reverse tet transactivator system. a, 
Soluble fraction Coomassie stain.  b, Pellet fraction Coomassie stain.  c, Soluble fraction western 
immunoblot.  d, Pellet fraction Coomassie immunoblot.  The doxy induced diploid shows expression, at 
both the expected size 29.5 kDa and also at higher bands.  The band between 100 and 150 kDa seems 
to be related to the band below 37 kDa, as they show the same expression pattern in lanes 5 and 7.  
Furthermore, it seems that all the tet system samples (3-7) have the larger band in the pellet fraction.   
1 2 3 5 4 6 7 1 2 3 5 4 6 7 
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 The cells were mixed in ratios ranging from 1:10 C2:C4 to 1:10
4
 C2:C4, in addition to running a 
100% C2 sample and a 100% C4 sample, with all cell samples containing a total of 10
8
 cells at the time of 
mixing.  The cell mixtures were induced in 2 µg/mL doxycycline for 72 hrs, and then multiple rounds of 
magnetic bead selection were conducted.  After three rounds of enrichment, a PCR assay was done 
based on restriction digestion of the PCR products (Figure 3-11).  The placeholder BC loop contains a 
ClaI cut site that the HA4 loop does not.  The HA4 cassette contains a BsiWI cut site that the template 
loop does not.  Therefore, cutting individually with these two restriction enzymes should give opposite 
cutting patterns when visualized on a gel.   
Figure 3-10.  Detection and Enrichment of 
Recombinants from Mock Libraries. 
Yellow “C2” cells possess a non-functional 
HA4 in the display plasmid and a fixing 
loop sequence in the cassette plasmid, 
and thus has the potential to reconstitute a 
functional binder.  Blue cells are C2 cells 
that have realized this potential by 
successfully recombining the fixing 
cassette into the display plasmid.  Red 
“C4” cells possess the non-functional HA4, 
but a dummy cassette plasmid, and thus 
have no ability to reconstitute a binder.  By 
mixing yellow cells with an excess of red 
cells we can make a “mock” library.  In the 
example shown, C2 and C4 cells are 





Indeed, library dilutions up to 10
3
 enriched cells missing the ClaI digestion site, which would be consistent 
with enrichment of cells that had replaced the placeholder BC. 
To corroborate these findings with flow cytometry, we labeled the 10
2
 dilution mock library with anti-V5 
against the yeast display construct (Figure 3-12). 
Figure 3-11.  Library size determination by recombination and enrichment.  DNA coding for the 
unrecombined BC loop cuts with ClaI but not BsiWI, whereas DNA coding for the recombined BC loop 
cuts with BsiWI but not ClaI, and thus there should be a mirror flip.  Library sizes are shown along the 
bottom and represent the minimum library size the initial proportion of C2:C4.  Thus mock library which 
started out with 1:10
3
 C2:C4 demonstrated reduced ClaI cutting compared to the control, and thus 
suggests that we can create libraries at least 10
3





Mating type switch in ysMDM100 to create mating partner 
Since, the EBY100 strain upon which all the yeast display strains are based is of mating type a, 
we needed to create a strain of the opposite type of mating type α, so that we could bring libraries of 
cassette plasmids together.  To do this, we used inducible expression of HO-endonuclease
22
 to create a 
mixed population of the two mating types, which were then separated into individual colonies by plating.  
The mating type of individual colonies was determined by PCR
23
.  The results are shown in Figure 3-13. 
 
After obtaining the separate mating type strains, the plasmid carrying the HO endonuclease was removed 
using a 5-FAA TRP1 counter-selection
24
. 
Figure 3-13.  Galactose 
induction of HO endonuclease 
results in a, α, and diploid cells.  
The PCR products of 16 different 
colonies from the same plate are 
shown here.  All three 
possibilities are represented, 
with MAT a cells producing a 
band above 500, MAT α cells 
producing a band at below 500, 




Figure 3-12.  Flow cytometry shows enrichment of cells displaying non-truncated 
monobody on surface.  Using 10
2
 dilution library.  Round # indicates rounds of 




3.4 Materials and Methods 
Construction of yeast display plasmids 
BC loops were constructed from synthetic oligos co-transformed into yeast with cut plasmid pGalR38A for 
gap-repair formation of the desired plasmid.  To make pHRS-YD2B, oligos MDM0066 and MDM0067 
were extended by PCR, and the product was gel purified and co-transformed into EBY100 yeast with 
ClaI-digested pGalR38A.  Colony growth on SC(UT-) plates indicated gap-repair, which was confirmed by 





 competent E. coli (New England BioLabs, Cat. # C2925), prepped and double 
digested with BclI and BsiWI (2.4 µg plasmid, 5 µL NEB buffer #3, 4 µL of BsiWI, 1 µL BclI, 50 µL total, 50 
°C overnight).  An insert BC sequence was produced by PCR extension (10 µL of 10x Thermopol buffer, 
1 µL of dNTP mix, 1 µL of MDM064A, 1 µL of MDM064C, 86.5 µL of ddH2O, 0.5 µL of VENT DNA 
polymerase).  The insert was purified by agarose gel and co-transformed into EBY100 yeast with the 
double-digested pHRS-YD2B.  Colony growth on SC(UT-) plates indicated gap-repair, which was 
confirmed by sequencing using MDM0035 and MDM0032. 
 
Construction of cassette plasmids 
 To make pHRS-Cas2, a DNA insert containing the BC loop sequence of HA4 was created by 
PCR: 10 µL 10x Thermopol buffer, 1 µL of dNTP mix, 0.5 µL of oligo MDM0075, 0.5 µL of oligo 
MDM0076, 86.5 µL H2O, 1 µL of pHFT2-HA4, and 0.5 µL VENT DNA polymerase.  The insert was gel 
extracted, and both insert and plasmid pRS425 were double-digested with SalI and BamHI in NEB buffer 
3 + BSA at 37 °C overnight.  Cut plasmid and cut insert were purified by agarose gel.  5.4 ng of cut 
pRS425, 183 ng of cut insert, 2 µL of 10x ligase buffer, and 1 µL DNA T7 ligase were combined in a 20 





Replacing HIS3 in EBY100 with KanMX 
The Saccharomyces Genome Database (www.yeastgenome.org), was used to retrieve the upstream and 
downstream sequences of PEP4 locus. 
Using primers MDM0120 and MDM0121, I copied the KanMX marker from plasmid HO-poly-KanMX4-
HO
25
.  The reaction mixture was: 1 µL oligo MDM0120, 1 µL oligo MDM0121, 1 µL dNTP mix, 10 µL of 
10x Thermopol buffer, 86 µL ddH2O, 0.5 µL of plasmid HO-poly-KanMX4-HO, 0.5 µL of VENT DNA 
polymerase.  1 µL of this PCR reaction was transferred directly into a second reaction mix for PCR 
extension: 1 µL MDM0130, 1 µL MDM0131, 1 µL of dNTP mix, 10 µL 10x Thermpol buffer, 85.5 µL of 
ddH2O, 0.5 µL of VENT DNA polymerase; program VENTLONG with 1 m 40 s extension time and Tm = 
52 °C.  The PCR product was gel purified, and 1 µg was pelleted by ethanol precipitation and transformed 
into yeast strain EBY100.  Transformants were plated on G418 (geneticin) media plates to select for 
successful insertion of KanMX.  Colonies that grew on geneticin were then patched onto both SC(HU-) 
and SC(U-).  If a strain grew on SC(U-) and not SC(HU-), it was deemed to have the HIS3 removed. 
Further evaluation was made by colony PCR of the yeast strains using the yeast colony PCR protocol 
(see Section 2.X.X) with 5 µL of 10x Thermopol buffer, 0.5 µL of 100 µM MDM0140, 0.5 µL of 100 µM 
MDM0141, 0.5 µL of dNTP mix, 0.5 µL of cell lysis mix, 42.5 µL of ddH2O, and 0.5 µL of VENT DNA 
polymerase.  This reaction was carried out with a thermocycler program of 52 °C annealing temperature 
and 2 min extension time.  Products were run on a 1.0% agarose gel at 120 V.   
 
Construction of I-SceI plasmid 
An insert containing the I-SceI ORF was made by PCR: 1 µL of oligo MDM0091, 1 µL of oligo MDM0092, 
1 µL of plasmid pDR001 containing the I-SceI ORF, 10 µL of 10x thermopol buffer, 1 µL of dNTP’s, 85.5 
µL ddH2O, and 0.5 µL of VENT DNA polymerase, with 50 °C annealing temperature and 1 min extension 
time per cycle (VENTLONG).  The PCR product was purified from a 2.0% agarose gel, run at 120 V for 20 
min. 
The PCR product, along with plasmids pCM251 and pCM252 were double digested: 5 µL NEB4 buffer, 5 
µL BSA, 35 µL of DNA to be digested, 2.5 µL of SbfI, and 2.5 µL of PmeI, and incubated overnight in a 37 
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°C water bath.  The digested DNA was gel purified, and then ligated: 2 µL of 10x ligation buffer, 4 ng  of 
plasmid (either pCM251 or pCM252), 130 ng of I-SceI insert, 1 µL of T4 DNA ligase, to a total of 20 µL, 
incubated at 16 °C for 10 hrs.  The ligations were then pelleted with EtOH precipitation and transformed 
into competent E. coli via electroporation.  Transformants were plated on LB + ampicillin plates.  The 
intermediate products pSceα1(from pCM251) and pSceα2 (from pCM252) were purified from these 
transformants via Qiagen mini-prep kit.  pSceα1 and pSceα2 were digested with EcoRV: 5 µL of NEB3 
buffer, 5 µL BSA, 39 µL of plasmid (2 µg total), 1 µL of EcoRV, incubated in a 37 °C water bath for at 
least 4 hrs. 
 
A HIS3 insert was created by PCR of the HIS3 from pRS423: 1 µL of MDM0150, 1 µL of MDM0151, 1 µL 
of dNTP mix, 1 µL of pRS423, 10 µL of 10x thermopol buffer, 85.5 µL ddH2O, 0.5 µL VENT DNA 
polymerase.  This HIS3 insert and the EcoRV-digested pSceα1/2 plasmids were gel purified by Qiagen 
gel extraction kit, pelleted and co-transformed into the desired yeast strain.  Gap-repair resulted in the 
desired pHRS-Sce plasmids. 
 
 
Time-course trial of doxycycline induction 
ysD1BC2S1, ysD1BC2S2, and ysD2BC2S1 were inoculated from patches into 5 mL cultures of 
SC(HUTL-) in a 30 °C shaker overnight.  The following day, took 1 mL of each culture (OD between 0.5 
and 1.4) for my “O/N” colony PCR sample, and transferred an additional 1 mL from each culture into 50 
mL SC(HUTL-) in flasks, and put shaking at 30 °C for an additional night.  The next day, I took 10
8
 cells 
from each flask for “Pre-Induction” sample, and then added 1 mg/mL doxycycline to a final concentration 
of 1 µg/mL in the flasks, and continued shaking.  A sample of 10
8
 cells was taken roughly every 24 hrs for 
up to 7 days.  The samples were immediately prepped using glass beads (see Chapter 2, Materials and 
Methods) and used in PCR: 10 µL GoTaq Buffer, 0.5 µL MDM0032, 0.5 µL of MDM0173, 0.5 µL of dNTP 





I-SceI expression western blots 
Made fresh SDS-PAGE gels 
Made fresh transfer buffer (1 L of 25 mM Tris, 150 mM NaCl, 0.05% Tween20, pH 7.5) using 3.036 g 
Trizma base, 8.766 NaCl, 500 mL of Tween20 for 0.05%. 
Empty microfuge tubes were weighed, and then 1 mL of each induction culture was added, spun 14 krpm 











Lysed yeast cells with the indicated amount of yeast protein extraction reagent (Y-PER from Thermo 
Scientific).  Vortexed until pellet fully suspended (at least 10 sec).  Put cells on rotator at RT for 20 min.  
Spun down cells from rotator 14 krpm, 10 min.  Took sup, added 6X SDS buffer.  Took pellet, added 30 
µL H2O, 30 µL 6X SDS buffer.  Boiled SDS samples for 5 min.  Loaded samples into gel and ran 1 hr at 
140 V.  Ran gels for pellet and sup, and duplicate gels for blotting and Coomassie staining and Western 
blot.  Standard ladder used was Precision Plus Protein™ Kaleidoscope Standards (Bio-Rad).    
 Cut a gel sized piece of nitrocellulose out and placed in DI water by laying gently on top.  Put the 
gels in transfer buffer, along with filter paper.  Cut a notch (for identification purposes) into the bottom 
right of the supernatant gel, into the top right for pellet gel.  Removed the nitrocellulose from the DI water 







1 1.0398 18.8 94 
2 1.0345 13.5 68 
3 1.0419 20.9 104 
4 1.0354 14.4 72 
5 1.0412 20.2 101 
6 1.0369 15.9 79.5 
7 1.0347 13.7 68.5 
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bottom, followed by the nitrocellulose sheet, then the first gel onto the stack, and rolled with glass pipette 
to get air bubbles out.  Trimmed to make sure each layer of the stack was the same shape.  Placed 2 
more pieces of filter paper.  Placed 2nd membrane, and then 2nd gel. 
 Confer with diagram on top of the Western apparatus for further details.  Hooked apparatus up to 
voltage source, ran at constant A = 40 mAmps for 1 hr. 
 To label the membranes, removed nitrocellulose membranes (making sure not to touch them with 
fingers).  Placed them in 5% dry milk in transfer buffer.  Put on shaker for 1 hr.  Added labeled anti-FLAG 
antibody.  Shook for 1 hr.  Added Amersham ECL prime reagent (GE Healthcare Life Sciences) following 
included instructions. 
 
Magnetic bead selections 
As described in chapter 2 
Some bead samples were kept uncoated to serve as negative selections for binders against streptavidin 
or the beads themselves.  The other bead samples were coated with at least 5 pmol of biotinylated target 
protein overnight on a rotator at 4 °C.   
 
Mock library enrichments 
Strains ysD1BC2S2 and ysD1BC4S2 were inoculated from plate colonies into 30 mL SC(HUTL-) and put 
shaking at 30 °C.  6 samples were made by mixing these two starting cultures in varying proportions.  All 
6 samples were mixed such that there were 10
8
 total cells in each.  A sample of 100% “C2” cells and a 
sample of 100% “C4” cells were made.  4 samples were made by mixing, with 1:10 C2:C4 in the first 
sample, 1:100 in the second sample, 1:1000 for the third, and 1:10
4
 for the fourth.  These represented 
libraries of hits “C2” that could potentially reconstitute a functional HA4 monobody through homologous 
recombination, with the C2 hits being rarer and rarer in the higher dilutions.  After mixing the cells from 
the appropriate two starter cultures, the 8 samples were spun down at 2800xg, 10 min, 4 °C.  The 
supernatant was poured off and the cells were resuspended in 10 mL of SC(HUTL-) for a starting OD600 
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of 1, and transferred to 50 mL sterile Erlenmeyer flasks.  Doxycycline was added to a final concentration 
of 2 µg/mL in each sample.  The flasks were then put shaking at 30 °C for 72 hrs. 
 10
8
 cells of the doxy induction were spun down 2800xg, 10 min, 4 °C, and were resuspended in 
15 mL of SG(HUTL-) media in a 50 mL conical tube.  The galactose inductions were put on a rotator at 23 
°C.  8 µL of resuspended magnetic beads (5x10
6
 beads) were added to microfuge tubes (two tubes for 
each of the 6 samples), and washed 2x with 1 mL of PBSF.  6 bead tubes were resuspended with 10 µL 
of 3.8 µM SH2-GST-biotin + 90 µL of PBSF for the positive selection coated beads, and the other 6 were 
resuspended with just 100 µL of PBSF for the negative selection uncoated beads, and all beads were put 
on a rotator in the cold room (4 °C) overnight. 
 The next day 4x10
8
 cells were taken from each galactose culture and spun down 2800xg, 5 min, 
4 °C.  The sup was discarded and each cell pellet was washed once with cold PBSF.  Then they were 
resuspended in 1 mL cold PBSF and added to the uncoated beads for negative selection.  The cells + 
uncoated beads were put on a rotator at 4 °C for 1 hr.  Meanwhile, the beads + SH2-GST-Biotin were put 
on the magnet and washed twice with 1 mL cold PBSF to remove unbound protein.  When the incubation 
on uncoated beads was finished, the cells + uncoated beads were put on the magnet at 4 °C for 5 min.  
The supernatant was pulled off with a pipette and added directly to the washed, coated beads.  These 
tubes were then incubated on the cold room rotator for an additional hour.  After this, the cells + coated 
beads were put on the magnet for 10 min.  The sup was pulled off and the beads were washed 2x with 1 
mL cold PBSF.  Then the washed beads were resuspended in 15 mL SC(HUTL-) in 125 mL Erlenmeyer 
flasks and put in the 30 °C shaker.  Once the cells reached an OD600 ≈ 1, then another round of 
selection would be started with galactose induction.  After each round, cells were glycerol stocked and 
also cell prepped for PCR analysis.   
Construction of opposite mating type yeast strains 
pGal-HO-TRP1 (AKA pFH800
22
) was a generous gift from the Symington Lab.  It was transformed into 
ysMDM100 by electroporation to create strain ysMDM200.   
A colony of ysMDM200 from a plate was inoculated into 5 mL of pre-induction culture (SD minimal, 2% 
raffinose, 0.1% glucose) and put shaking overnight at 30 °C.  The cells were then centrifuged at 2800xg 
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for 5 min.  The supernatant was poured off, the cells were washed with 5 mL of sterile ddH2O.  The cells 
were spun down another 5 min and the supernatant poured off.  Then the cells were resuspended in 5 mL 
induction culture (SD minimal, 2% galactose, 0.1% glucose), and put shaking at 30 °C for 5 hrs.  After 
this, the cells were washed once with ddH2O and then dilution plated on YPD. 
 
Individual colonies were prepped by SDS protocol (see Chapter 2 Materials and Methods).  PCR 
reactions were run according to Huxley
23
.  Recipe: 20 uL GoTaq Buffer, 1 uL ODR0143, 1 uL ODR0144, 
1 uL ODR0145, 1 uL dNTP’s, 74.5 uL H2O, 1 uL VENT, and 0.5 uL lysed cells in SDS prep.  
Thermocycling was for 30 cycles of 92 °C for 1 min, 58 °C  for 2 min, 72 °C for 2 min, and the PCR 
products were run on an agarose gel (Figure 3-X). 
 
To remove the pGal-HO-TRP1 plasmid (to make room for the TRP1 containing yeast display plasmid), a 
TRP1 counter selection with 5-FAA was used
24
.  5-FAA containing plates were made in the following way.  
Glucose (12.5 g), Bacto agar (5 g), and ddH2O water added to 100 mL were mixed together and then 
autoclaved.  Immediately after autoclaving, I added 2X SD (125 mL), 10X amino acid supplement (25 mL, 
see below), and 5-FAA (1.25 mL of 10% w/v in EtOH), and then poured 25 mL per plate.   
The 10X amino acid supplement was made in the following way.  0.011 g tryptophan, 0.025 g adenine, 
0.025 g uracil, 0.025 g methionine, 0.025 g arginine, 0.027 g histidine, 0.031 g tyrosine, 0.059 g lysine, 
0.081 g leucine, 0.078 g isoleucine, 0.039 g phenylalanine, 0.150 g valine, 0.085 g glutamate, 0.382 g 
serine were added to a 500 mL flask with ddH2O added to 100 mL total volume.  This was autoclaved, 
and then while the solution was cooling (at around 50 °C), 0.06 g aspartic acid and 0.2 g threonine were 
added to the solution, which was swirled the solutes were fully dissolved.  25 mL of this amino acid mix 
was added to the above 5-FAA plate recipe. 
 Individual colonies of MAT a and MAT α type were grown in 5 mL of YPD overnight at 30 °C, and 
10x and 1000x dilutions were plated (100 µL each) onto the 5-FAA plates.  This was done gently because 
the plates were very soft and fragile. 
 Colonies that grew on the 5-FAA plate were then replica patched onto SC(U-) and SC(UT-) plates 




3.5 Strains, Plasmids, and Oligonucleotides 
Table 3-1.  Strains used in this study 
Name Details Source/Reference 
EBY100 MATa ura3-52 trp1 leu2Δ1 
his3Δ200 pep4:HIS3 prb1Δ1.6R 
can1 GAL yeast display Aga 
system 
 
ysMDM100 EBY100 with pep4:HIS3 replaced 
with KanMX 
 
ysMDM200 ysMDM100 with pGal-HO-TRP1  
ysD1BC2S1 ysMDM100 with pHRS-YD1B, 
pHRS-Cas2, and pHRS-Sce1 
 
ysD1BC2S2 ysMDM100 with pHRS-YD1B, 
pHRS-Cas2, and pHRS-Sce2 
 
ysD2BC2S1 ysMDM100 with pHRS-YD2B, 




Table 3-2.  Plasmids used in this study 
Name Details Source/Reference 
pGalR38A  Chapter 2 
pHRS-YD1B Yeast display plasmid expressing 
HA4 with placeholder BC loop 
 
pRS423 2µ HIS3 pBIISK ori amp
R
  
pRS425 2µ LEU2 pBIISK ori amp
R
 ATCC #77106  
pHRS-Cas2 pRS425 with HA4 BC loop  
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pCM251 tetO2  
pCM252 tetO7  
pSceα1 tetO2  
pSceα2 tetO7  
pHRS-Sce1 tetO2  
pHRS-Sce2 tetO7  
pDR001 I-SceI  
HO-poly-KanMX4-HO KanMX GenBank: AF324728 / 25 


















MDM0075 TAATAATTCCGTCGAC TAGGGATAACAGGGTAATGTTCCGACCAAACTGGAAG 
MDM0076 ATGTTGATAAGGATCC ATTACCCTGTTATCCCTATGGTACAGTGAATTCCTGAAC 
MDM0091 TACACATGAG GTTTAAAC CGGATTCTAGAACTAGTATGG 
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MDM0140 AGC CTA CCA CGT AAG GGA AG 
MDM0141 CTG AGG ACA AGA TGG TTT GTC 
MDM0150 TATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCT  GAT TGT 
ACT GAG AGT GCA CC 
MDM0151 CTTGCAGGCAAGTGCACAAACAATACTTAAATAAATACTACTCAGTAATAAC  ATA TCG 
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Mating Libraries for the Combination of Loop Diversity 
 
4.1 Abstract 
 In this chapter, we affinity mature an HA4 binder using the complete heritable mutagenesis 
system, the individual components of which  (having developed the separate components in the previous 
chapters).  We used yeast mating to combine libraries with mutations in either the BC or the FG loops, 
resulting in a library that had mutations in both loops.    Galactose induction was used to initiate 
homologous recombination, and the resulting yeast were selected with magnetic beads and FACS in 
order to obtain populations enriched with higher affinity binders.  We discuss the different library 
strategies, and present flow cytometry data that shows how the library populations change after rounds of 
selection.  Higher affinity populations were obtained with two different BC loop diversities.   
4.2 Introduction 
 In the past chapters, we validated the different components that were required to construct a 
system for mutation and selection in vivo, and confirmed their proper functioning.  With that done, it was 
time to begin mating libraries and selecting binders.   
Past efforts in affinity maturation have utilized yeast mating to combine diversity. In 2004, 
Weaver-Feldhaus and colleagues demonstrated that yeast mating could be used to bring together 
antibody heavy chain (VH) and light chain (Vk) libraries to create a combinatorial library of Fab fragments
1
.  
In their system, VH chains were expressed as fusions to the Aga surface proteins, and Vk chains were 
translated independently and secreted into the culture medium.  These Vk chains could successfully form 
disulfide linkages to the VH chains, and thus Fab fragments were constituted on the surface of the yeast.  
In a demonstration of their system, this group PCR-amplified VH and Vk sequences from a human 
volunteer immunized with botulinum toxin to create a 3x10
6
 member VH library and a 5x10
5
 member Vk 
library in separate yeast strains.  These yeast strains were then mated to give 3x10
9
 unique diploids.  
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Screening this diploid library with magnetic beads and FACS yielded 5 Fab fragments with affinities for 
botulinum toxin ranging from 0.8 – 2.1 nM. 
 Following up on this initial work, they then applied this system towards the affinity maturation of 
high-affinity antibodies against botulinum toxin
2
.  Their starting binders were 3 scFv proteins, one which 
bound a botulinum neurotoxin A1 domain with Kd = 5 nM, and two which bound botulinum subtype B 
domains with around Kd = 3 nM.  In this system, the heavy chains of the starting binders were not varied, 
but mating of yeast was used to combine a single heavy chain with a library of 5x10
5
 light chains taken 
from a human immune repertoire.  These library members were sorted with 6 rounds of FACS, and the 
loop sequences of the obtained hits were grafted onto human IgG1 scaffold.  The three hits, one for each 
of the starting binders, were found to have Kd’s ranging from 25.1 – 6.59 pM, with an average affinity 
increase of 37-fold. 
 Although this work demonstrated the power of mating to quickly affinity mature binders, it has a 
major limitation for more general application.  Light chains and heavy chains are intrinsically separate.  If 
we wanted to mutate two different regions within the same domain (say a single-domain catalytic 
enzyme), we would not be able to use this system.  Even within the field of antibody binders, it might be 
the case that we want to combinatorially diversify two loops within the same domain, in which case 
domain shuffling cannot help.  A more general solution is needed that can combine libraries that code for 
diversity in arbitrary locations within the target protein.  In our proposed system, the diversity is encoded 
in cassettes and is targeted to the proper location within the gene of interest by homology.  Thus, 
separate libraries can target the same domain, or different domains of the same protein, or even 
altogether separate genes on separate chromosomes for applications like enzymatic pathway 
engineering.  All that matters is the sequence information contained within the flanking homology regions.  
If the goal of affinity maturation is to use an already known good binder as a starting point to 
discover a great binder, we wanted to know if it would be a useful to exhaustively search the 
neighborhood in sequence space around the good binder.  Without having additional biophysical 
information, it is reasonable to operate on the assumption that mutants that are closer in sequence will 
tend to be more similar in function? 
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Decades of alanine scanning mutagenesis experiments have shown that changing a single amino 
acid can have a very dramatic effect on function.  Usually, these experiments aim to impair function.  But 
if these single mutations can significantly impair function, then that implies that the reverse mutation 
significantly improves function.  In affinity maturation, we have our starting sequence, corresponding to 
good function.  We don’t want to throw away the good residues, but in general we won’t know which ones 
are good and which ones are bad.  So ideally, we would want some way of systematically working 
through all the mutants in a conservative manner, keeping most of the protein the same. 
Instead of leaving it up to chance, we can use the low cost of oligo synthesis to exhaustively 
search every loop that is similar to the existing loop.  How do we define “similar?”  The Hamming distance 
concept, which finds applicability in computer science and information theory, can also be applied to 
protein and DNA sequences
3
.  This seems a reasonable place to start.  It is reasonable to hope that the 
set of all amino acid sequences with H = 1 compared to our starting loop will have many members that 
have similar properties.  Certainly, certain key residues, when mutated to any of the other 19, might 
abolish binding function.  But if we wanted to do an exhaustive search of a certain set of loop sequences 
that could fit within a limited library size and that had a reasonable chance of containing functional hits, a 
reasonable strategy might be to search every loop sequence with H < X, X chosen so that the total 
theoretical complexity can fit within the library size searchable by the available experimental methods. 
For example, for a library (set) of all BC loop sequences with H ≤ 2 compared to the HA4 BC 
sequence (8 residues long), the theoretical diversity would be: 
   
 
  × 48  = 6.45 × 10  
We have a 48
2
 term instead of a 20
2
 term because we are using NNB codons, where B = C,G, or T 









Table 4-1.  Theoretical “Hamming 2” (H ≤ 2) library complexities for different types of diversity 
 NNB codons NNY codons 
8 residue loop 6.45 x 104 2.87 x 104 
10 residue loop 1.04 x 105 4.61 x 104 
13 residue loop 3.59 x 105 1.60 x 105 
 
 
This type of library design is extremely amenable to the cassette-based loop swapping that our 
genetic system is designed for.   
I also needed to show that strains based on EBY100 could successfully mate.  Wittrup’s yeast 
display system
4
 relies critically on the use of Aga1p and Aga2p, proteins on the surface of yeast that 
function in mating between a and α cells.  The monobody protein is fused to the Aga2p protein, and that 
allows it to be displayed on the yeast cell surface.  However, fusing an exogenous protein to Aga2p might 
interfere with its natural function.  Work by Nobel and coworkers
5
 has showed that aga2 mutations impair 
mating efficiency in liquid culture to 0.1% compared to wild-type.  Mating efficiency on solid medium was 
unaffected, which would be consistent with the idea that aga2p facilitates (but is not essential for) a and α 
cell mating by holding the cells in proximity to each other
6
.  Since our mating is intended to be done on 
solid medium, these studies were reassuring.  However, we needed to characterize mating in our system, 
anyway, due to its importance in horizontal genetic transfer. 
Another important source of genetic diversity are existing libraries.  We decided it would be 
interesting to make a library of loops taken from a library that was already enriched against the binder, 
and then mate that combine that library with a library of our own design for another loop.  In their paper 
describing the HA4 binder
7
, Wojcik and co-workers obtained an intermediate library with an aggregate Kd 
> 500 nM, before doing affinity maturation to arrive at the HA4 clone.  We decided to pull out the FG loop 





Fully random NNB and NNY libraries in cassette plasmid 
These libraries are the same type of diversity as the mixed-length BC libraries discussed in Chapter 2.  
The two libraries (NNB and NNY codon diversity) were transformed into cassette plasmids in different 
mating types.  In order to maximize library complexity, each of the 4 sub-libraries (corresponding to a 
specific codon length of 6, 7, 8, or 9) was transformed separately, and then the successful transformants 
were combined.   
 
 











The 4 NNB libraries of different lengths in MAT a yeast were combined to make mixed-length library of complexity 
1.99x10
7
.  The 4 NNY libraries in MAT α were combined to make a library of complexity 2.61x10
7
.   
 
An enriched library of FG loops 
In their 2010 paper, Wojcik and co-workers built an initial binder library by randomizing the BC, 
DE, and FG loops and then selecting for SH2 binders with phage display
7
.  This gave them an 
intermediate library, which was then loop-shuffled to give HA4.  We obtained this intermediate library 
(which I will simply refer to as “Wojcik Library”) from the Koide Lab and cloned the FG loops into the yeast 
display plasmid via PCR and gap-repair.   We sequenced the colony PCR products from this yeast library 
to get a sense of the type of library diversity.  We found that 48.39% of the FG loops in our sample were 
the HA4 FG loop sequence (high affinity). 
MAT a  MAT α  
6 NNB codons  1.7 x 10
6
  6 NNY codons  5.5 x 10
6
  
7 NNB codons  6.1 x 10
6
  7 NNY codons  7.7 x 10
6
  
8 NNB codons  4.4 x 10
6
  8 NNY codons  4.4 x 10
6
  
9 NNB codons  7.7 x 10
6
  9 NNY codons  8.5 x 10
6
  
Sum  1.99 x 10
7



















Mating full NNB/NNY libraries with Wojcik FG library 
To test mating, we took yeast cells containing NNY/NNB cassette plasmids (conferring growth in 
Leu- media) and mated them with yeast cells containing FG libraries in yeast display plasmids (conferring 
growth in Trp- media).  Only diploids resulting from the mating of the two had both plasmids, and could 
thus grew on (Leu- Trp- media).  4x10
8
 cells of each mating type were mixed together and allowed to 
mate on YPD plates for 6 hrs.  Following this time, the cells were resuspended and dilution plated on 
selective media (HU- or HUTL-) plates to determine the number of diploids. 





were estimated to be capable of growth on HU-, whereas 4x10
5
 cells (or 0.18% of total pairs) were 
estimated to be capable of growth on HUTL- (and thus counted as diploid).  In the mating of NNB library 




 pairs) were estimated to be capable of growth 
on HU-, whereas 1.8x10
6
 cells (or 0.51% of total pairs) were estimated to be capable of growth on HUTL-.  
FG Sequence Occurrence Frequency 
WGEDSAGYMFMYS 15 48.39 
WGEDXXGDMFMYS 1 3.23 
SYSNLNYGYSYYS 2 6.45 
SYSNLN*GYCYYS 1 3.23 
FKHKYGYAFYYS 1 3.23 
RYPYWMWYSDS 1 3.23 
SWYDYYGYSYDS 1 3.23 
WHYWFYYYS 1 3.23 
WSDGVEYMHESS 1 3.23 
WWWYSSSSS 1 3.23 
WYHGWQYGS 1 3.23 
WYYDLNYG*F*YS 1 3.23 
YDYEWWQYS 1 3.23 
YGYPEAYGS 1 3.23 
YSYFGYDS 1 3.23 
YYHTSHYDHYS 1 3.23 
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Thus we found that we could obtain ~ 10
6
 diploids by mating.  Since the recombination efficiency is more 
of a bottleneck, this is a very adequate output. 





After switching to the new FITC labeling method, much improved results were observed for an NNB x 
Wojcik FG library (Figure 4-2). 
 
 
Figure 4-1.  Fully random BC x Wojcik FG, after one round magnetic beads. 
Both have a significant population of single-positive PE cells (see discussion). a, NNY BC x Wojcik FG.  





Hamming 2 BC loop library 
We decided to randomize residues MSSSSVYY from the HA4 BC loop, which keeps the upstream proline 
that might force the BC loop into a proper confirmation.  This library randomizes the two residues that 
make direct contact with the SH2 domain. 
 
 The transformation of the H2BC library into a cassette plasmid resulted in 6.0x10
6
 transformants 
(strain ysL-CasH2BC).  Further transformation with cut yeast display plasmid to give transfer of the library 
Figure 4-3.  Mutational scheme for H2BC library.  
8 residues from the HA4 BC loop sequence 
(shown across the top) were chosen for mutation.  
28 oligos were ordered from IDT, with every 
combination of 2 out of 8 codons being 
randomized to NNB.  This is a low diversity library 
with a relatively low theoretical complexity. 
Figure 4-2.  NNB x Wojcik FG after 1 round of 
beads and 1 round of FACS.  Higher affinity 
population is present with lower FITC signal 
but higher PE signal. 
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cassette resulted in 8.6x10
5
 transformants (H2BCgap library), which is still 13X the theoretical library 
diversity. 
 
We also constructed a yeast display library of  H2BC diversity directly by co-transformation of 
cassettes with cut yeast display plasmid, with gap-repair giving the desired product, “H2BCvitro”.   This 
library could be compared to the one created by doxycycline induction and homologous recombination.   
 
Figure 4-4.  Population sequencing of H2BC library.  This sequencing data was 
obtained from the finished PCR insert, prior to transformation and gap-repair into 
a cassette plasmid.  Black arrows mark the first and last nucleotide of the 24 bp of 
diversified codons.  For any specific codon out of the 8, we predict it would be 
mutated in 7 out of the 28 codons (25% of the time).  The other 21 oligos have the 
wild type nucleotides for that codon.  This trace data is reasonable, then, although 
there appears to be some additional mutation.  There is a repeating pattern of 
absence of A (green) signal every third nucleotide, which is consistent with our 




 After obtaining the flow cytometry results shown in Figure 4-X, we felt very felt very confident that 
the current FITC labeling protocol was insufficient.  After this point, we switched to a labeling scheme with 
mouse anti-V5 primary and goat anti-mouse Alexa Fluor 488 secondary.   
 
Figure 4-5.  FITC labeling scheme inadequate for high cell density.  a, 10
6





NNY x WojFG.  Judging from the single-positive populations in b 
and c, it was clear that the FITC labeling reagent wasn’t able to handle the cells  
(a) 






In Figure 4-X, we show the FITC signal from ysEBYHA4 populations labeled with no FITC reagent, 
labeled with the old method (4-Xb), and labeled with the new method (4-Xc).  The stark improvement in 
intensity confirmed the superiority of the primary-secondary labeling method. 
Figure 4-6.  An improved method for 
labeling yeast display.  ysEBYHA4 cells 
labeled with, a, no FITC label reagent, 
b, anti-V5-FITC, and c, mouse anti-V5 









Mating H2BC library with Wojcik FG Library 
 
We mated 100x excess of WojFGa with enriched H2BCgap aiming to drive as much of H2BCgap to 
diploid as possible.  Diploids were induced with doxycycline to induce homologous recombination of the 








Figure 4-8.  H2BCvitro after 1 round of FACS.  A 
large percentage of clones are high-affinity. 





Yeast display of peptidase heterozygotes 
FY250 (type α) was mated with ysEBYHA4 (type a) with 100x excess of FY250.  This diploid was then 




 The fact that we were doing the FITC labeling sub-optimally in the past explained a lot of times 
that we’ve seen a lot of single-positives.  On the down-side, it means we actually need to rerun a lot of 
our libraries.  On the plus side, it seems like we have had hits all along in our various libraries. 
 In this chapter, we begin testing binder libraries that are the result of two loop libraries coming 
together.  For FG loop diversity, we used an intermediate library that ultimately led to the discovery of 
HA4.  Many of these FG loops have affinity for SH2, despite their diverse sequences.  This is an 
interesting opportunity to see if multiple mutational paths can lead to alternative solutions to the binding 
problem.   
 For our BC loop library, we have two different library design.  First, we used the same completely 
random, mixed-length libraries that we used in Chapter 2, and mated these to the Wojcik FG loops.  
Figure 4-9.  Diploids that are heterozygous for 
yeast display knock-outs can still express 




Figure 4-2 showing the NNB x Wojcik FG diploids after 1 round of beads and 1 round of FACS shown is 
very exciting, and it will be very interesting to sequence the high affinity sequences. 
 Our second library takes the strategy of a low-diversity library, where no sequence is more than 2 
amino acids away from the HA4 BC.  I conceptualize this strategy in the following way (Figure 4-X shows 
the idea for a simplified library)..  Take the protein sequence that you are trying to affinity mature, and put 
it in the center of sequence space, with all other protein sequences of the same residue length arranged 
around it in concentric circles.  On the first circle place all protein sequences that differ by 1 mutational 
step (Hamming Distance H = 1, following the terminology of Bosley
3
).  On the second circle place all the 
protein sequences that require two mutational steps to reach from your center, and so forth for the rest of 
the circles.  The shells contain more and more sequences and get bigger and bigger until the final shell, 
which includes all sequences of the same residue length which have no residues in common with your 
sequence.  The Hamming Library mutational strategy is then to figure out the experimental library size 





Figure 4-10.  Hamming Shells.  For a 
3-residue long protein, with 4 amino 
acid diversity.  Each concentric circle 
contains all the nodes of that 
Hamming distance.  The first circle 
contains all nodes with H= 1 from 
AAA, the second circle with H=2.  
There will be as many circles as the 
residue length of the starting 
sequence.  Third and final circle for 
this example is not shown for 
simplicity.  Each single mutational 
step is represented either as a dotted 
line or as physical contact between 
nodes.   
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Our H2BC libraries show many binders with high-affinity, even without enrichment steps.  It will be very 
interesting to sequence these libraries and see what kinds of patterns emerge.  Furthermore, with this 
many functional mutants all slightly different from each other in sequence, it will be interesting to see 
which Wojcik FG loops are pulled out of the Wojcik FG library. 
 We are currently in the process of building an H2FG library which will provide another interesting 
FG library to mate with. 
 As can be readily seen, the number of possible library mating combinations grows rapidly as we 
build loop libraries with different types of diversity.  That is really one of the great strengths of combining 
the heritable mutagenesis system with a monobody protein, where the functional loops that we wish to 
target are well defined.  We can create many different loop libraries for the BC and the FG loops, and 
store them in the fridge.  They will be just as valuable for future targets as they are for the current one. 
 
Materials and Methods 
Determining mating efficiency 
Determined OD600 for cell density of O/N cultures of ysMDM322, ysMDM422, ysL-NNY6789, and ysL-
NNB6789.  Took 4 x 10
8
 cells from each library for 20x coverage of 2x10
7
 BC loop complexities.  Mixed 
ysMDM422 with ysL-NNB6789, and ysMDM322 with ysL-NNY6789. 
Spun cells at 2800xg, 10 min, 4 °C.  Dumped supernatant, resuspended cells in 200 µL YPD and pipetted 
all of the resuspension into the center of YPD plates without spreading.  Put the plates in 30 °C incubator 
right-side up for 6 hrs.  Recovered cells by washing 3x with 1 mL of ddH2O and collecting washes with a 
pipette.  Made dilutions and plated to determine mating efficiency. 
Inoculated recovered mated diploids into 50 mL of SC(HUTL-) for propagation and glycerol stocks.  3 





Building fully random BC loop libraries into cassette plasmid 
The overall scheme for building the BC mutagenesis cassettes. 
 
The first step of the PCR reaction: 1 μL of MDM0232, 1 μL of dNTP’s, 1 μL of 5’ oligo (1 of the 8 
following: MDM0423-0426 for varying lengths of NNB, MDM0453-0456 for varying lengths of NNY), 20 μL 
of GoTaq Buffer, 76 μL of H2Os, and 1 μL of GoTaq polymerase; thermocycled with 10 cycles of 30 sec 
95 °C, 30 sec annealing (56 °C), and 1 min 
extension, with final 10 min extension.  Ran PCR products in 2% agarose gel (Figure 4-9) and purified 
with Qiagen gel extraction kit. 
 
This product was then used in the second step: 1 μL of MDM0231, 0.5 μL of MDM0431, 5 μL (250 ng) 
PCR product from step 1, 1 μL of dNTP mix, 20 μL of GoTaq Buffer, 71.5 μL of H2O, and 1 μL of GoTaq 
DNA polymerase.  Thermocycler program was 25 cycles, annealing temperature was  54 °C.  A separate 
reaction was done for each of the 8 loop libraries. 
Figure 4-11.  First step of random BC cassette 
synthesis.  The varying lengths of the BC loop (6, 7, 8, or 
9 codons) can actually be visualized in the slight difference 
in gel migrations.  The bright bottom band is the product, 
which was excised and purified. 
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The step 3 PCR reaction created a 3’ fragment: 1 µL dNTP mix, 1 µL MDM0234, 0.5 µL MDM0233, 20 µL 
GoTaq Buffer, 76.5 µL H2O, and 1 µL GoTaq DNA polymerase. 
Step 4 was an extension joining of the products directly from step 2 and step 3.  Recipe: 40 µL of 5’ 
fragment PCR rxn (1 of the 8 samples from Step 2), 40 µL of 3’ fragment PCR rxn (Step 3), 1 µL of 
dNTP’s, and 1 µL of GoTaq DNA Polymerase.  Note:  neither PCR fragment is purified; they are both 
coming straight from the previous PCR reactions and thus are still in GoTaq buffer. 
This reaction mix underwent 10 cycles of 30 sec melting, 30 sec annealing, 1 min extension.  The finished 
reaction was run on 2% agarose gel at 120 V for 20 min.  The band at 250 bp was excised and purified by 
Qiagen gel extraction kit.  This product was used in a final amplification PCR step: 1 µL of MDM231amp, 
1 µL of MDM234amp, 1 µL of dNTP mix, 1 µL of purified step 4, 75 µL of H2O, 20 µL of GoTaq buffer, 
and 1 µL of GoTaq DNA polymerase.  The product was gel purified. 
 Plasmid pRS425 was digested: 5 µL NEB3 buffer, 5 µL BSA, 20 µL of pRS425 maxiprep (15.4 
µg), 18 µL of H2O, 1 µL of SalI (20 Units), and 1 µL of BamHI (20 Units).  The digestion reaction was 
incubated in a 37 °C water bath overnight, and then gel purified. 
 3 µg of this double-cut pRS425 was pelleted with 6.2 – 9.0 µg of one of the 8 BC library diversity 
cassettes.  The 4 NNB diversity cassettes were electroporated into ysMDM320 and the 4 NNY diversity 
cassettes into ysMDM420.  Gap-repair within the yeast resulted in a cassette plasmid encoding a 
randomized BC loop cassette.  Transformants were dilution plated on SC(HUL-) and SC(HU-) to 
determine transformation efficiency and thus estimate library size.  From liquid cultures, the 4 libraries of 
different length for a give codon type (e.g., NNB) were combined by taking 20x the estimated complexity 
of each length and mixing into a single flask. 
 
 
Building Wojcik FG library into yeast display plasmid 
The C-terminal end of 
10
Fn3 was cloned out of Wojcik’s plasmid library: 1 µL of 100 µM forward primer 
MDM242, 1µL of 100 µM reverse primer MDM241, 1 µL of dNTP mix, 20 µL of GoTaq Buffer (5X), 75 µL 
of H2O, 1 µL of Wojcik pDSB library, 1 µL of GoTaq polymerase; Program:  30 cycles with 58 °C 
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annealing, 20 sec extension, and 10 min final extension.  The bright 195 bp band was excised and 
purified by gel extraction. 
The PCR product was then digested with EcoRI to remove any sequences that non-specifically included 
the BC loop from Wojcik’s library: 34 µL of PCR prep (roughly 2.5 µg), 10 µL H2O, 5 µL 10x EcoRI buffer, 
1 µL EcoRI enzyme, 37 °C bath O/N. 
 
pHRS-YD1B was double digested with XhoI and SalI: 5 µL NEB3, 5 µL BSA, 38 µL of pHRS-YD1B, 1 µL 
XhoI, and 1 µL SalI, incubated in a 37 °C bath O/N.  This was gel purified.  
 
3 µg of Wojcik FG insert was then pelleted with 1 µg of double-cut pHRS-YD1B and then contransformed 
into ysMDM320 and ysMDM420 to make strain ysL-WojFGa and ysL-WojFGα, respectively. 
 
Building H2BC library 
1
st
 step: 1 µL of 0232, 1 µL of dNTP’s, 1 µL of H2BC mix, 20 µL of GoTaq Buffer, 76 µL of H2O, 1 µL of 
GoTaq DNA polymerase, GOTAQSHT program with 10 cycles of 30 sec melting, 30 sec annealing (50 
°C), 20 sec. extension, with final 10 min extension.  The reaction was run on agarose gel, and the bright 
product band at 100 bp was excised and gel extracted.   
 
H2BC mix is was created by mixing equal amounts of the 28 individual oligos: 
1 Oligo MDMH2BC01 5'-TACGTGATACGGTA VNNVNNAACAGAAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
2 Oligo MDMH2BC02 5'-TACGTGATACGGTA VNNGTAVNNAGAAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
3 Oligo MDMH2BC03 5'-TACGTGATACGGTA VNNGTAAACVNNAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
4 Oligo MDMH2BC04 5'-TACGTGATACGGTA VNNGTAAACAGAVNNAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
5 Oligo MDMH2BC05 5'-TACGTGATACGGTA VNNGTAAACAGAAGAVNNAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
6 Oligo MDMH2BC06 5'-TACGTGATACGGTA VNNGTAAACAGAAGAAGAVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 




8 Oligo MDMH2BC08 5'-TACGTGATACGGTA ATAVNNVNNAGAAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
9 Oligo MDMH2BC09 5'-TACGTGATACGGTA ATAVNNAACVNNAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
10 Oligo MDMH2BC10 5'-TACGTGATACGGTA ATAVNNAACAGAVNNAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
11 Oligo MDMH2BC11 5'-TACGTGATACGGTA ATAVNNAACAGAAGAVNNAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
12 Oligo MDMH2BC12 5'-TACGTGATACGGTA ATAVNNAACAGAAGAAGAVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 
13 Oligo MDMH2BC13 5'-TACGTGATACGGTA ATAVNNAACAGAAGAAGAAGAVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
14 Oligo MDMH2BC14 5'-TACGTGATACGGTA ATAGTAVNNVNNAGAAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
15 Oligo MDMH2BC15 5'-TACGTGATACGGTA ATAGTAVNNAGAVNNAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
16 Oligo MDMH2BC16 5'-TACGTGATACGGTA ATAGTAVNNAGAAGAVNNAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
17 Oligo MDMH2BC17 5'-TACGTGATACGGTA ATAGTAVNNAGAAGAAGAVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 
18 Oligo MDMH2BC18 5'-TACGTGATACGGTA ATAGTAVNNAGAAGAAGAAGAVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
19 Oligo MDMH2BC19 5'-TACGTGATACGGTA ATAGTAAACVNNVNNAGAAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
20 Oligo MDMH2BC20 5'-TACGTGATACGGTA ATAGTAAACVNNAGAVNNAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
21 Oligo MDMH2BC21 5'-TACGTGATACGGTA ATAGTAAACVNNAGAAGAVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 
22 Oligo MDMH2BC22 5'-TACGTGATACGGTA ATAGTAAACVNNAGAAGAAGAVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
23 Oligo MDMH2BC23 5'-TACGTGATACGGTA ATAGTAAACAGAVNNVNNAGACAT
 CGGCGCATCCCAGCTGATCAGC-3' 
24 Oligo MDMH2BC24 5'-TACGTGATACGGTA ATAGTAAACAGAVNNAGAVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 
25 Oligo MDMH2BC25 5'-TACGTGATACGGTA ATAGTAAACAGAVNNAGAAGAVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
26 Oligo MDMH2BC26 5'-TACGTGATACGGTA ATAGTAAACAGAAGAVNNVNNCAT
 CGGCGCATCCCAGCTGATCAGC-3' 
27 Oligo MDMH2BC27 5'-TACGTGATACGGTA ATAGTAAACAGAAGAVNNAGAVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
28 Oligo MDMH2BC28 5'-TACGTGATACGGTA ATAGTAAACAGAAGAAGAVNNVNN
 CGGCGCATCCCAGCTGATCAGC-3' 
 
Step 2: 1 µL of MDM0231, 0.5 µL of MDM0431, 5 µL PCR product #1, 1 µL of dNTP’s 
20 µL of GoTaq Buffer, 71.5 µL of H2O, 1 µL of GoTaq polymerase. 
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Program  GOTAQSHT with 54 °C annealing temp, 10 cycles, 10 min final extension.  Gel purified band at 
≈212 bp.   
Step 3:  1 µL dNTP’s, 1 µL 0234, 0.5 µL 0233, 20 µL GoTaq Buffer, 76.5 µL H2O, 1 µL GoTaq DNA 
polymerase; program GOTAQSHT, 10 cycles, 20 sec extension.  Gel purified band. 
Step 4:  1 µL dNTP’s, 44 µL step 3 product (13.86 pmol total), 34 µL step 2 product (13.906 pmol total), 
20 µL GoTaq Buffer, 1 µL GoTaq polymerase; Program GOTAQSHT with 10 cycles of 30 sec melting, 30 
sec annealing  @ 54 °C, 1 min extension.  Ran product on 40 mL gel made of 2.5% agarose at 120 V, 
and excised and gel purified. 
Step 5 (a final amplification): 1 µL of 0231amp, 1 µL of 0234amp, 1 µL of dNTP’s, 1 µL of product from 
Step 4, 75 µL of H2O, 20 µL of GoTaq buffer, 1 µL of GoTaq polymerase.  Program GOTAQSHT (melt 30 
s, anneal 30 sec 54 °C, ext 20 s, 20 cycles).  Purified from gel. 
1.8 µg of SmaI-cut pRS425 and 12.2 µg of BC library insert were pelleted and co-transformed into the 
strain ysMDM420 to make strain ysL-CasH2BC. 
 From ysL-CasH2BC, there were two possible routes to go to insert the library into HA4.  The first 
was to transform cut pHRS-YD2B into ysL-CasH2BC.  3 µg of pHRS-YD2B digested with BclI and BsiWI:  
5 µL NEB3 buffer, 23 µL ddH2O, 20 µL (5.2 µg) pHRS-YD2B, 1 µL (15 U) BclI, 1 µL (10 U) BsiWI; 
incubated in 50 °C water bath.  Double cut plasmid was gel purified and electroporated into ysL-
CasH2BC to make ysL-H2BCgap. 
 For the construction of the H2BCvitro strain, PCR was done with 1 µL of 100 µM MDM0232, 1 µL 
of dNTP mix, 1 µL of 100 µM MDM0431, 1 µL of 10 µM H2BCmix aas defined above, 20 µL of GoTaq 
Buffer, 75 µL of H2O, 1 µL of GoTaq DNA polymerase; program GOTAQSHT, 15 cycles of 30 sec 
melting, 30 sec annealing @ 50 °C, 20 sec extension with final 10 min extension. 
Building H2FG library 
Just as I have the template BC loop plasmid for the H2BC library, I wanted to build a template FG loop 
plasmid for the H2FG library: 20 µL of 5x GoTaq (Green), 2 µL of MDM264, 2 µL of MDM266, 2 µL of 10x 
dilution of MDM265, 1 µL dNTP’s, 72 µL H2O, 1 µL of GoTaq DNA polymerase.  Purified product from 3% 
agarose gel.   
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  Digested 2 µg HRS-YD2B for ligation 
  I will also digest all of my insert (22.7 µg) 
  Recipe: 
   5 µL NEB3 
   5 µL BSA 
   1 µL SalI 
   1 µL XhoI 
   10 µL plasmid or 38 µL insert (FG template cassette) 
Purified digested plasmid and insert by gel, and ligated with Quick Ligase Kit (New England 
BioLabs).  3 µL of plasmid (60 ng) was aliquoted into a microfuge tube 
.A 3x molar ratio of insert was called for; 5.14 ng insert was added.  ddH2O was added to a total of 10 µL.  
10 µL of 2x quick ligase buffer was added.  1 µL of quick ligase enzyme was added; mixed rxn thoroughly 
with a pipette.  Incubated rxn at RT on benchtop for 5 min, then put on ice in 2 µL aliquots.  Competent 
TG1 aliquot from -80°C freezer was thawed on ice (5-10 min).  Added 50 µL of competent cells to the 2 
µL aliquot of ligation rxn; mixed via pipette.  Incubated on ice 15 min.  Electroporated cells, rescued with 1 
mL LB, put shaking at 37 °C.  Plated on LB+amp. 
 
Mating H2BC library with Wojcik FG library  
Mixed 50 µL Lib13-2 (1.4 x 10
6
) with 5 mL of WojFGa  (1.7 x 10
8
 cells) 
 Mixed 40 µL Lib15-2 (1.3 x 10
6
) with 5 mL of WojFGa  (1.7 x 10
8
 cells) 
Spun down 10 min at 3500 rpm, then dumped sup 
Resuspended cells in 200 µL YPD, then dropped into center of a YPD plate 
Put in 30 °C incubator face up at 12:00 
 
Building library strains 
pHRS-Sce2 (with  I-SceI expressed under the strong tetO7 promoter) was transformed into ysMDM300 




Doxycycline stocks were made by addiong 3.7 mg to 3.7 mL ddH2O, mixed by inversion 
Filter sterilized through 0.2 micron filter. 
 
Flow cytometry 
Cells were induced (total # = 20X library complexity) in selective SG media for 24-36 hrs (Chapter 2).   




 cells) into individual 1.5 mL microfuge tubes.  
Pelleted cells @ 14,000xg for 30 sec in 1.5 mL microfuge tube.  Removed sup with pipette and washed 
with 1 mL cold PBSF.  Scaling for every 10
7
 cells in a sample, resuspended the sample in 100 µL PBSF + 
1 µL SH2-GST-Biotin + 0.5 µL mouse anti-V5 antibody.  Vortexed to break up cell clumps.  Put rotating 
for 30 min – 1 hr, either at RT or 4 °C, depending on desired stringency of selection.  Note: all following 
steps were done on ice.  Pelleted cells for 30 sec @ 14,000xg.  Washed with ice-cold 1 mL PBSF.  
Scaling for every 10
7
 cells in a sample, resuspended cells in 100 µL of PBSF + 0.5 µL of Streptavidin-PE 
+ 1 µL Alexa488-anti-mouse antibody).  Rotated in cold room for 15 min.  Pelleted cells for 30 sec @ 
14,000xg 
Washed with ice-cold 1 mL PBSF.  Removed sup and left pellets on ice. Immediately before running 
cytometry on the sample, resuspend pellet in 250-800 µL of cold PBSF, vortexed briefly. 
 
Labeling 
 Used 0.5 µL PE in 100 µL (1:200) 
 Used 1 µL anti-V5-FITC in 100 µL (1:100) 
 Used 0.5 µL mouse anti-V5 in 100 µL (1:200) 
 Used 1 µL anti-mouse 488 in 100 µL (1:100)     
Testing yeast display in peptidase heterozygotes 
Mixed 50 µL of HA4 in EBY100 (0.98 x 106 cells) with 1 mL of FY250 (1.3 x 108) 
Using an excess of FY250 to drive mating of all HA4; I want to be sure that I have 
diploids when I test yeast display ability. 
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Spun down 10 min at 3500 rpm, then dumped sup 
Resuspended cells in 200 µL YPD, then dropped into center of a YPD plate 
Put in 30 °C incubator face up at 12:00 
 
4.6 Strains, Plasmids, and Oligonucleotides 
Table 4-4.  Strains used in this study 
Name Details Source/Reference 
EBY100 MATa ura3-52 trp1 leu2Δ1 
his3Δ200 pep4:HIS3 
prb1Δ1.6R can1 GAL yeast 
display Aga system 
 
ysMDM100 EBY100 with pep4:HIS3 




Table 4-5.  Plasmids used in this study 
Name Details Source/Reference 
pHRS-YD1B   
pHRS-YD2B   
pRS425 2µ LEU2 pBIISK ori amp
R
 ATCC #77106  
pHRS-Cas2 pRS425 with HA4 BC loop  
pHRS-Sce1 tetO2  
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We are now at a very exciting point with our technology.  After overcoming a number of technical 




 Perhaps the most exciting new direction right now is just to build many different libraries, mate 
them, and see how they look on flow cytometry. 




Characterization of Binding Hits 
 Conveniently, flow cytometry is an excellent way for measuring affinity of individual binders
5,6
.  




 SPR is a flexible and robust technique for the characterization of binding kinetics for an 
interaction between a protein and its ligand
8,9
.   
 ITC is a technique that can determine Kd without the use of labels
10
.  We have already begun 





Re-run old libraries with new labeling 
In Chapter 4, we discovered a method for FITC labeling that resulted in increased intensity signal by an 
order of magnitude.  We realized that our old labeling method could only handle cell numbers less than 
10
6
, but we were running 10
8
 cells in some of our libraries. 
 
Specificity and additional SH2 domains 
It would be interesting if we could use CDR walking  technique to move from a high-affinity binder for one 
SH2 domain to another SH2 domain.  Given the high degree of structural similarity between the SH2 
domain family members, it is likely that a library developed for one will contain binders with some affinity 
for another.  It would be really interesting to see if, while developing binders to multiple different SH2 
domains in parallel, cross pollination from a library for target A into a library for target B could help the 
target B library move out of local minima in the search for more globally optimal solutions. 
Figure 5-1.  ITC data for the binding of HA4 
10
Fn3 to GST-SH2. 
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Improved Mutagenic Systems 
 Although our system was effective in bringing together diversity from two different libraries, 
searching sequence space is always a numbers game.  All other things equal, better results will be 
obtained with larger library sizes.  Going forward, a high-yield area for optimization of the technology will 
be in increasing the efficiency of the homologous recombination step. 
 One way to do this is to move the location of DNA double-strand break (DSB).  In the current 
system, double-strand breaks are introduced on the flanks of the mutagenic cassette, which sits in the 
cassette plasmid.  According to the current model, DNA resection creates single strands at the loose 
ends of the cut, which can then invade into the yeast display plasmid and initiate homologous 
recombination.  However, the cassette plasmid is multi-copy, which means that there are roughly 20 
copies per cell
11
, whereas the yeast display plasmid is low-copy, with roughly 1-2 copies per cell
12
.  
Although the cassette in the cassette plasmid contains homology to the display plasmid, it clearly 
contains even greater homology, as it is in fact identical, to the 20 additional copies of the cassette 
plasmid within the same cell.  Assuming no differences or biases between display and cassette plasmids 
in terms of intrinsic propensity for recombination, we would then expect that it is 20x more likely for a DSB 
within a given cassette plasmid to undergo the trivial, undesired homologous recombination event with an 
identical copy than to undergo the desired gene replacement repair with the display plasmid. 
It is very reasonable to expect that the efficiency of homologous recombination would be 
improved by at least one order of magnitude (possibly more) if the site of DSB was moved to the middle 
of the 
10
Fn3 gene in the yeast display plasmid, ideally in the framework region between the BC and FG 
loops.  One way to do this might be through the use of introns.  With an intron, you could put an SceI cut 
site directly between two loops at the DNA level, but it wouldn’t be translated at the protein level. 
Another alternative for mutagenesis is to generate the mutagenic cassettes by expressing mRNA 
at high copy and using a reverse transcriptase to generate DNA cassettes from the RNA, which could 
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A word about serial processes affecting library complexity 
It is important to inquire how my library complexity will be affected by lab bench procedures.  A 
few papers have developed some basic mathematical descriptions for the manipulation of protein 
libraries
1–3
.  An important rule of thumb, derived from Table 2 from Denault
1
, is that when dealing with 
library complexities of 10
6
, you need to work with a multiplicity of 20x (2x10
7
 cells) in order for the 
probability of losing a unique clone to be 0.21%  This is derived by using a Poisson distribution to 
represent the probability of loss of a unique clone from the library.  This applies to any manipulation, even 
using a pipette to transfer cells from one tube to another.  If instead, I only transfer 10
7
 cells (10x of my 
complexity) the probability is ~100% that I have lost one of my unique clones.  Thus, in all of the work 
described in this thesis relating to libraries of cells, I have made every effort to carry 20x my current 
estimate complexity through to the next step. 
If I perform multiple library manipulations in a row, how is my overall library complexity affected?  
The following considerations are of a more “back-of-the-envelope” nature than the papers described 
above.    
Due to the fact that our libraries are cells, and cells can be grown up and duplicated after each 
step, it can be readily shown that, to a first approximation, final complexity after the 3 manipulations is 
only a function of the single step with the lowest efficiency (i.e., the bottleneck).  Let’s say I start out with a 
library complexity of 10
8
.  And I perform three manipulations in a row (where a manipulation can be a 
mating, a selection, an induction step, etc.).  Manipulation 1 has an efficiency of 10%, Manipulation 2 has 
an efficiency of 0.01%, and Manipulation 3 has an efficiency of 1%.  If I took the cells output from one 
manipulation directly into the next, then I would simply multiply these all together.  After the first, I’d have 
10
7
 cells, after the second, I’d have 10
3
, and after the third, I’d only have 10 cells left.   
Since I grow the cells to saturation after each step, I am really only limited by the number of cells I 
can physically grow.  For most manipulations that are relevant to this work, the maximum number of yeast 
cells we can work with is 10
10
.  100 mL can get sufficient oxygenation from being grown in a 500 mL flask 





 cells, to the chagrin of my labmates who might also want to utilize the 30 °C shaker.  This is 
about the ceiling of what is practical to work with on a non-industrial scale. 





growing in culture.  Now, on average, I have 100 copies of each clone from the 10
8
 library.  Then I 
undergo Manipulation 1, with efficiency of 10%.  This take me to 10
9
 cells; 10 out of the 100 copies is 
successfully output.  I grow back up to 10
10
 cells, then undergo Manipulation 2, with efficiency of 0.01%.  
Now I’ve only got 10
6
 cells successfully output, and I’ve lost 99% of my 10
8
 sequence complexity.  I grow 
up to 10
10
 again, so that I have 10
4
 copies of each of my 10
6
 clones now, and undergo Manipulation 3, 
with efficiency 1%, and my library complexity is unchanged since 1/100 doesn’t make much of a dent in 
the 10
4
 multiplicity for each unique clone. 
Whenever the library size is at a high multiplicity of the complexity, these simple efficiency 
multiplications will hold.  When I am dealing with low multiplicity, then statistical fluctuations will result in 





Programs for Mining Sequence Data 
#0035 sequence processing.R 
#This script harvests BC and FG loop sequences from primer 0035 reads of  
#the FN3 protein in pYD (yeast display) plasmids. 
 
#read in bioinformatics packages 
library(seqinr) 
 
# set the directory that contains the sequencing data of interest 




# create an empty list that will be used to store raw DNA sequencing data 
rawDNA <- list() 
# read all of the fasta format DNA sequences in the current directory into rawDNA 
for (i in 1:length(dir())){ 
 tempSeq <- read.fasta(file = dir()[i], seqtype = "DNA")  





#  the very beginning of the FN3 protein is marked by this nucleotide seq: GTTTCTTCT 
# create list that will hold all of the translated protein sequences 
fn3Prot <- list() 
121 
 
# for every raw data sequence that we have… 
for (i in 1:length(rawDNA)) { 
# …pick out the numerical address at which that FN3 protein sequence begins 
 FN3start <- regexpr("gtttcttct", c2s(rawDNA[[i]]))   
 if (FN3start != -1){  #if FN3 start location was successfully found 
  FN3end <- length(rawDNA[[i]])   #set an end-point 
# translate a protein sequence from the beginning of 
10
Fn3 to the end of the raw DNA read 
  trans <- translate(rawDNA[[i]][FN3start:FN3end], frame = 0, sens = "F")  
# add this translation to the growing list of translations 





#Create lists to hold just the BC loop and FG loop sequences 
bcSeq <- list() 
fgSeq <- list() 
 
for (i in 1:length(fn3Prot)) { 
# find the starting and ending positions of the bc loop in the sequence array 
# start: SLLISW 
# end: YYRITYG 
trans <- fn3Prot[[i]] 
 bcStart <- regexpr("SLLISW", c2s(trans)) 
 bcEnd <- regexpr("YYRITY", c2s(trans)) 
# if we have sequences for the two regions flanking the BC loop 
 if(bcStart != -1 && bcEnd != -1) 
# Pull out the residue sequence and store it in bcSeq 
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  bcSeq <- c(bcSeq, list(trans[(bcStart+6):(bcEnd-1)])) 
 
# Do the same for the FG loop 
 fgStart <- regexpr("TITVYA", c2s(trans)) 
 fgEnd <- regexpr("PISINY", c2s(trans)) 
 
 if(fgStart != -1 && fgEnd != -1)  
  fgSeq <- c(fgSeq, list(trans[(fgStart+6):(fgEnd-1)])) 
} 
rm(fgStart, bcStart, fgEnd, bcEnd, trans, i) 
 
# reformat the structure of the data so that it can be saved as a CSV table 
bcStr <- lapply(bcSeq, c2s) 
bcStr <- unlist(bcStr) 
fgStr <- lapply(fgSeq, c2s) 
fgStr <- unlist(fgStr) 
 
# write data to CSV table 
write.table(table(bcStr), file="bc table.csv", sep=",") 












#0035 sequence processing.R 
#This script harvests BC and FG loop sequences from primer 0032 reads of  
#the FN3 protein in pYD (yeast display) plasmids. 
 
#read in bioinformatics packages 
library(seqinr) 
 
#set the directory that contains the sequencing data of interest 




#create a list with each element a raw DNA sequence read 
rawDNA <- list() 
#read DNA sequence in fasta format into a list called rawDNA 
for (i in 1:length(dir())){ 
 tempSeq <- read.fasta(file = dir()[i], seqtype = "DNA") 




#create list of translated protein sequences 
#the very beginning of the FN3 protein: GTTTCTTCT 
fn3Prot <- list() 
for (i in 1:length(rawDNA)) { 
124 
 
 FN3start <- regexpr("gtttcttct", c2s(rawDNA[[i]]), fixed=TRUE)  #pick out location that FN3 DNA 
sequence begins 
 if (FN3start != -1){ #if FN3 start location was successfully found 
  FN3end <- length(rawDNA[[i]])   #set an end-point 
  trans <- translate(rawDNA[[i]][FN3start:FN3end], frame = 0, sens = "F") #translate a 
protein sequence 





#Read out the BC loop sequences 
bcSeq <- list() 
fgSeq <- list() 
 
for (i in 1:length(fn3Prot)) { 
 #find the starting and ending positions of the 
 #bc loop in the sequence array 
 #start: SLLISW 
 #end: YYRITYG 
 trans <- fn3Prot[[i]] 
 bcStart <- regexpr("SLLISW", c2s(trans)) 
 bcEnd <- regexpr("YYRITY", c2s(trans)) 
 
 if(bcStart != -1 && bcEnd != -1) 
  bcSeq <- c(bcSeq, list(trans[(bcStart+6):(bcEnd-1)])) 
 
 fgStart <- regexpr("TITVYA", c2s(trans)) 
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 fgEnd <- regexpr("PISINY", c2s(trans)) 
 
 if(fgStart != -1 && fgEnd != -1)  
  fgSeq <- c(fgSeq, list(trans[(fgStart+6):(fgEnd-1)])) 
} 
rm(fgStart, bcStart, fgEnd, bcEnd, trans, i) 
 
bcStr <- lapply(bcSeq, c2s) 
bcStr <- unlist(bcStr) 
fgStr <- lapply(fgSeq, c2s) 
fgStr <- unlist(fgStr) 
write.table(table(bcStr), file="bc table.csv", sep=",") 
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